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Vinculin is a 117kDa soluble cytoplasmic protein that localizes to focal adhesions. 
Biochemical studies show that vinculin tail binds actin and vinculin head binds talin.  
These ligand binding interactions imply a role for vinculin as a mechanical linker 
between the actin cytoskeleton and the extracellular matrix.  The consensus within the 
field is that expression of vinculin increases the adhesion of cells to the extracellular 
matrix and slows cellular migration speed.  Vinculin is also implicated in the cellular 
mechanotransduction response because focal adhesion size is positively correlated with 
increased traction force between a cell and its substrate and because vinculin is recruited 
to focal adhesions with the application external force to a cell.  The binding sites for 
many of vinculin’s ligands are regulated by an autoinhibition mechanism inherent to the 
structure of vinculin.  However, it is unknown how vinculin’s autoinhibition and 
vinculin’s interactions with its ligands regulate vinculin’s role in cellular migration and 
mechanotransduction.   To study vinculin’s role in these processes, a panel of vinculin 
ligand binding and autoinhibition mutants were expressed in an embryonic fibroblast line 
isolated from a Vcl-null mouse.  I used timelapse microscopy to quantify the effect of 
vinculin and vinculin mutants on the speed of randomly migrating cells.  My data shows 
that the presence of vinculin has no significant effect on cell speed.  This result was 
unexpected, but it is in agreement with one other publication on the random migration of 
Vcl-null versus vinculin-expressing cells.  To investigate another phenotype of vinculin-
expressing cells, I developed a device capable of introducing uniaxial stretch to silicone-
based cell culture chambers.  This device was used to apply stretch to live cells in order 





My data shows that mature focal adhesions do not increase in size or number with greater 
frequency than unpaired, timelapse controls.  This lack of force-dependent change in 
mature focal adhesions suggests the hypothesis that effects of external forces are 
restricted to a different subpopulation of focal adhesions, possibly nascent focal 
adhesions. 
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Vinculin was originally isolated serendipitously from chicken gizzard smooth muscle and 
characterized as a cytosolic protein that localizes to regions where microfilament bundles 
meet membrane attachment sites to the extracellular matrix (Geiger, 1979; Burridge and 
Feramisco, 1980; Geiger et al., 1980).  As a novel protein with unknown function, it was 
named vinculin from the Latin word vinculum, meaning a bond signifying a union or 
unity (Geiger, 1979; Peng et al., 2011), because its localization supported the proposal 
that the function of vinculin might be to participate in the linkage of the termini of 
microfilament bundles to cell membranes.  In the 30 years since its discovery, the study 
of vinculin has expanded to include animal, biochemical, structural and in vivo functional 
studies to determine the role of vinculin in biology.    
 
The function of vinculin in animals: 
Vinculin is an actin cytoskeleton-associated protein that is expressed in most cells and 
tissues (Geiger et al., 1980; Otto, 1990) and is enriched in numerous cell-matrix or cell-
cell adhesion junctions (Geiger et al., 1980), including the dense plaques of smooth 
muscle (Geiger et al., 1980), subsarcolemmal lattices, and costameres of skeletal and 
cardiac muscle (Pardo et al., 1983a; Pardo et al., 1983b; Craig and Pardo, 1983; Shear 
and Bloch, 1985; Danowski et al., 1992; Ervasti, 2003), myotendinous junctions (Shear 
and Bloch, 1985), and intercalated discs (Pardo et al., 1983a; Koteliansky and Gneushev, 
1983).  Vinculin is highly conserved and is necessary for embryonic development 
(Bakolitsa et al., 2004) in mice (Xu et al., 1998a) and worms (Barstead and Waterston, 
1991), but not in Drosophila (Alatortsev et al., 1997).  C. elegans carrying mutant copies 
of vinculin are paralyzed and have disorganized muscle.  Vcl-null C. elegans fail to 
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connect their myofibrils to the plasma membrane and die at an early larval stage because 
they cannot move to feed (Barstead and Waterston, 1991).  Mice heterozygous for 
vinculin expression are predisposed to stress-induced cardiomyopathy (Zemljic-Harpf et 
al., 2004) while Vcl-null mice have an embryonic lethal phenotype with severe heart and 
brain abnormalities (Xu et al., 1998a).  Mice with cardiac myocyte specific excision of 
the vinculin gene die due to sudden cardiac death secondary to disruption of cell:cell 
junctions (Zemljic-Harpf et al., 2007).   Analyses of human tissue samples from patients 
with dilated cardiomyopathy (Maeda et al., 1997; Olson et al., 2002) show a correlation 
with hereditary mutations in a muscle specific splice-variant of vinculin, metavinculin 
(Byrne et al., 1992).  Cholinergic contraction of canine tracheal smooth muscle tissue 
results in localization of vinculin to the cell membrane (Opazo Saez et al., 2004; Huang 
et al., 2011).   Furthermore, there is decreased tracheal smooth muscle contractility when 
mutants of vinculin that prevent the appropriate activation or ligand binding of 
endogenous vinculin are expressed (Huang et al., 2011).  Combined, these studies 
indicate that vinculin is involved in the assembly or maintenance of transmembrane 
linkages that allow the intracellular cytoskeleton to transmit force.   
 
Vinculin is recruited to newly forming focal adhesions: 
Vinculin localizes to dynamic connections called focal adhesions that link the actin 
cytoskeleton of a cell to the extracellular matrix (Bloch and Geiger, 1980; Geiger et al., 
1980; Alenghat et al., 2000; Ziegler et al., 2006).  It is known that vinculin is recruited to 
focal adhesions as they mature (DePasquale and Izzard, 1987; Izzard, 1988; Ezzell et al., 
1997).  Recent advances in our understanding of focal adhesion development indicate 
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that vinculin is present throughout focal adhesion maturation (Choi et al., 2008).  Before 
focal adhesion formation, the leading edge of migrating cells, also called the 
lamellipodium, contains dendritic actin, Arp 2/3, and cofilin.  Within the lamellipodium, 
nascent focal adhesions assemble in an actin-dependent, myosin-independent manner, 
and contain vinculin, paxillin, FAK, zyxin, and GlT1.  These nascent focal adhesions are 
short lived (60s) and typically dissemble as the wave of depolymerizing actin at the rear 
of the lamellipodium passes them by (Choi et al., 2008).  However, if the leading edge of 
a cell pauses, some nascent adhesions grow and elongate along actin filaments anchored 
to the focal complexes (Choi et al., 2008) in a Rac-dependent manner (Nobes and Hall, 
1995; Galbraith et al., 2002) to form focal complexes.  Focal complexes are twice as 
large as nascent focal adhesions, myosin activity dependent, and found mainly at the 
lamellipodium-lamellum interface (Choi et al., 2008).  Focal complexes continue to 
mature along centripetally-oriented stress fibers in a Rho-dependent manner (Izzard, 
1988) as actin filaments become increasingly crosslinked by alpha-actinin and myosin II 
(Choi et al., 2008; Oakes et al., 2012) and provide a template for the hierarchical addition 
of additional focal adhesion components (Choi et al., 2008).  Vinculin’s presence 
throughout focal adhesion maturation indicates that vinculin may play a key role in the 
function of focal adhesions within cells. 
 
Studies on the structure and biochemistry of vinculin provide insight on vinculin’s 
function: 
Structural (Bakolitsa et al., 2004) and biochemical studies (Coutu and Craig, 1988; Price 
et al., 1989; Cohen et al., 2005) show that vinculin is a 117kD modular protein with a 
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head domain (Vh) and a tail domain (Vt) that are linked by a flexible proline-rich region 
(Bakolitsa et al., 2004) (Figure 1-1).   
 
Figure 1-1:  Structure of full-length vinculin in its autoinhibited state. Domains are shown in 
different colors: D1, residues 6–252; D2, 253–485; D3, 493–717; D4, 719–835; D5 (Vt), 896–
1066. A short N-terminal strand ('N', residues 1–5) precedes D1. The proline-rich region (838–
878) is partly disordered and precedes a 'strap' (residues 878–890), that lies across the surface 
of Vt and the C terminus ('C'). The known ligands for each domain are indicated and the text 
color matches the color of the domain of vinculin to which the particular ligand binds.  (Modified 









The function of vinculin is highly autoinhibited by the coupled interaction of two 
relatively low affinity interfaces between its head and tail domains (Johnson and Craig, 
1994; Johnson and Craig, 1995b; Bakolitsa et al., 2004).  The flexible hinge region 
between Vh and Vt aids in this autoinhibition by preventing the diffusion of Vh from Vt.   
As a result, vinculin must be activated before it can bind to known ligands (Cohen et al., 
2005), and models of vinculin activation depend on the interruption of head-tail 
interactions (Cohen et al., 2006). Activation can occur through simultaneous binding of 
two of vinculin’s ligands talin and F-actin (Chen et al., 2006).  However, purified intact 
vinculin is tightly autoinhibited (Johnson and Craig, 1994; Johnson and Craig, 1995b) 
and does not bind its ligands in solution, with the exception of IpaA, a Shigella flexneri 
bacterial invasin protein (Bourdet-Sicard et al., 1999).  The ability of IpA to activate 
vinculin may reside in the presence of three vinculin binding sites (VBSs) in the C-
terminus of the IpaA protein that molecularly mimic that sites for in talin for 
vinculin:talin interaction (Izard et al., 2006; Park et al., 2011) and in the presence of 
more than one IpA binding site on vinculin (Nhieu and Izard, 2007). 
 
Since vinculin has no intrinsic enzymatic ability, activated vinculin must accomplish its 
functions through binding of its ligands.  Purified domains of vinculin have been shown 
to bind in vitro to several components of focal adhesions complexes (FACs); including 
talin (Burridge and Mangeat, 1984), alpha-actinin (Belkin and Koteliansky, 1987) 
paxillin (Turner et al., 1990), F-actin (Jockusch and Isenberg, 1981; Jockusch et al., 
1993; Menkel et al., 1994; Johnson and Craig, 1995b), VASP (Brindle et al., 1996; 
Reinhard et al., 1996), Arp 2/3 (DeMali et al., 2002), and vinexin/ponsin (Kioka et al., 
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1999).  Vinculin also binds acid phospholipids (Johnson and Craig, 1995a), with highest 
selectivity for PIP2 (Palmer et al., 2009).  The role of these ligand interactions with 
vinculin in the cell and how they regulate vinculin function has not been tested.   
 
FRET studies have shown vinculin’s conformation is variable at focal adhesions, with 
lower autoinhibition conformations present in peripheral focal adhesions and higher 
autoinhibition conformations present in the cytoplasm and retracting areas of the cell 
(Chen et al., 2005).  This indicates that vinculin activation is involved with both the 
formation of nascent focal adhesions and recruitment of vinculin to existing focal 
adhesions.   
 
Suggested functions for vinculin in cells: 
It has been difficult to pinpoint precisely how vinculin performs its function in cells.  
Vinculin’s presence in focal adhesions, its highly autoinhibited nature, and its many 
binding partners has challenged researchers to determine how the structure of vinculin 
and its ligand binding state may contribute to its cellular functions. Their findings suggest 
that vinculin may play a variety of roles within the cell.   
 
Evidence that vinculin regulates cell adhesion and motility: 
Vinculin head (Vh) co-localizes with talin, which localizes to cell-matrix adhesions 
(Burridge and Mangeat, 1984; Gilmore et al., 1992).  Vinculin (Vt) binds F-actin 
(Menkel et al., 1994; Johnson and Craig, 1995b).  These binding partners combined with 
vinculin’s localization to sites of actin-filament associated cell adhesion indicate that one 
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role of vinculin may be as a mechanical linker between the actin cytoskeleton and talin 
(Geiger, 1979; Geiger et al., 1980; Johnson and Craig, 1995b; Humphries et al., 2007). 
 
As a mechanical linker, vinculin may regulate focal adhesion formation.  As an example, 
vinculin’s interaction with talin activates transmembrane integrin heterodimers (Ohmori 
et al., 2010).  These activated integrins may then cause the phosphorylation of Focal 
Adhesion Kinase (FAK) (Guan et al., 1991; Kornberg et al., 1991) or bind directly to 
FAK (Schaller et al., 1995; Schaller and Parsons, 1995).  FAK functions as a scaffolding 
protein shown to interact with talin (Chen et al., 1995), paxillin (Turner and Miller, 1994; 
Schaller and Parsons, 1995), and when autophosphorylated, generates docking sites for 
various Src-kinases (Cobb et al., 1994; Schlaepfer et al., 1994; Xing et al., 1994).  These 
studies indicate that vinculin may regulate focal adhesion formation through involvement 
in talin-mediated integrin activation and affecting the localization of additional focal 
adhesion protein to initial ECM:integrin attachment sites.   By regulating focal adhesion 
assembly, vinculin could regulate cell adhesion and motility.   
 
The effect of Vcl knockout on cellular adhesion and motility has been studied extensively 
in both Vcl-null embryonal carcinoma and fibroblast cell-lines (Table 1-1).  Vinculin-
deficient F9 mouse embryonal carcinoma (EC) cells adhere less well to their substrates, 
contain smaller focal adhesions, and extend fewer lamellipodia than wild-type F9 cells 
(Samuels et al., 1993; Goldmann et al., 1995; Volberg et al., 1995).  When plated on a 
micropatterned substrate to separate effects of cell spreading from measurements of cell 
adhesive strength, Vcl-null F9 EC cells have 20% lower adhesion than wild type cells 
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(Gallant et al., 2005).  Vcl-null fibroblasts isolated from primary sources and from culture 
lines also show less adherence on fibronectin-coated substrates (Xu et al., 1998a; Xu et 
al., 1998b), a more rounded morphology (Rodriguez Fernandez et al., 1993) and higher 
migration rates than wild type cells in both wound healing and Boyden chamber assays 
(Rodriguez Fernandez et al., 1993; Xu et al., 1998a; DeMali et al., 2002).  However, of 
two recent publications studying vinculin’s effect on cell speed in random migration 
(Mierke et al., 2010; Fraley et al., 2010), only one found a speed difference between Vcl-
















Table 1-1:  Summary of previously published studies on the role of vinculin on cellular motility and/or speed. 










WT cells, endogenous vinculin level 
WT+20%, overexpressed chicken vinculin 
 
 
1.  Wound Healing 
2.  Phagokinetic tracks 
     on colloidal gold  
     surfaces 
1.  WT+20% were 3-4x slower closing wound 
    and had 3-4x shorter tracks than WT 
2.  WT cells moved 4x less   







Balb/C 3T3  
clone A31 
 
WT:  endogenous vinculin levels 
Null:  transfect vinculin antisense DNA  
          (incomplete knockdown) 
1.  Wound Healing 
2.  Phagokinetic tracks    
     on colloidal gold  
     surfaces 
1.  Cells with reduced vinculin migrate at least  
     2x further into wound 
2.  Cells with reduced vinculin have tracks 2x  








WT:  endogenous vinculin levels 
Null:  obtained by EMS mutagensis of the  
         WT cells.  
Filopodia extension 
 
WT cells extended filopodia at 58 nm/s while 








WT:   endogenous vinculin levels 
Null:  obtained by homologous  
         recombination with a   
         vinculin targeting vector 
1.  Phagokinetic tracks 
     on colloidal gold  
     surfaces 
2.  Wound Healing 
1.  Null cells had a 2.4x longer track than WT 
2.  2.4x more null cells migrated into scratch 









WT:  vinculin transfected into isolated  
         null line 
Null:  isolated from Vcl-null mouse pups 
         (homologous recombination) 
1.  Boyden Chambers 
2.  Migration away from 
     a cell aggregate 
 
1.  Null cells had 2x more migration across  
     the membrane.  Vh had 3-4x the migration 
2.  Confirmed that Vh alone increased  
     migration over Vh+Vt 
Xu 1998b 
 
MEFs Cells isolated from +/+ or -/- mice that 
spontaneously immortalized in culture 
(Adamson cell-lines) 
1.  Boyden Chambers 
2.  Wound Healing 
1.  Nulls moved 3-9-fold more than WT  
     across membrane 
2.  Nulls filled 50% of the gap by 6 hrs, while  
     WT only filled 10% 
DeMali 2002 MEFs WT:  gift of the Adamson lab 
Null:  gift of the Adamson lab 
Transwell chambers Null cells had 2x more migration across the 
membrane. 
Mills 2005 F9 PE  
 
WT:  F9 teratocarcinoma line 
Null:  F9 vin -/-, gift of the Adamson lab 
Migration away from cell 
aggregate 
Loss of vinculin promotes a 2x increase in 
outgrowth 
Mierke 2010 MEFs Adamson WT or vin-/- lines or similar lines 
derived from vin-/- or WT littermates by 
immortalization with large T-antigen (Mierke)  
 
1.  Timelapse   
     photography 
2.  Collagen invasion  
     assay 
1.  Nulls move 3x faster than WT on collagen 
2.  WT show 9-fold increase in invasive cells 
     compared to null cells 
 
Marg 2010 MEFs Isolated from embryos and immortalized with 
large T-antigen 
Collagen invasion assay WT show 6-fold increase in the % of invasive 
cells compared to Vcl-nulls 
Fraley 2010 HT1080  WT:  untransfected cells 
Null:  transfect with shRNA vinculin 
Timelapse photography No speed difference between the knockdown 
and WT in 2D or 3D 
Footnotes:   
a.  Wound healing:  Cell migration into a scratch wound on a confluent layer    e.  MEF:  mouse embryo-derived fibroblast cell-line 
b.  EMS:  ethyl methanesulfonate        f.  HT1080:  human fibrosarcoma cell-line 
c.  EC:  embryonic carcinoma 
d.  PE: parietal endoderm (made by treating EC with retinoic acid, causing differentiation into parietal endoderm)
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Truncation mutants of vinculin have been expressed in cells and analyzed for changes in 
motility compared to Vcl-null and wild-type cells.  Vcl-null mouse embryonic fibroblasts 
(MEFs) expressing only vinculin head (Vh) have a distinctly different migration pattern 
than cells expressing only vinculin tail (Vt). Vh-expressing cells are more adherent than 
Vcl-null cells, have a more rounded shape, and are more motile than Vcl-null cells.  In 
contrast, Vt cells are less adherent than Vcl-null cells and have 6-fold less migration than 
vinculin cells (Xu et al., 1998b).  However, Vt localizes to actin stress fibers whereas Vh 
and vinculin does not (Humphries et al., 2007), and so the observed motility differences 
may also be due to differences in the localization of Vh versus Vt.  To date, no study has 
investigated how vinculin regulates cell adhesion and motility using mutants of vinculin 
that contain specific point mutations that affect binding to particular ligands, rather than 
using truncation mutants of vinculin. 
 
Mutants of vinculin with lowered autoinhibition have been reported (Cohen et al., 2005).  
Expression of autoinhibition mutants in Vcl-null cells results in more numerous and 
longer focal adhesions (Cohen et al., 2005; Humphries et al., 2007).  Furthermore, FRAP 
studies have shown that autoinhibition mutants of vinculin are turned over more slowly 
within focal adhesions (Cohen et al., 2006; Humphries et al., 2007).  From this data, one 
could hypothesize that expressing an autoinhibition mutant of vinculin would result in 
increased focal adhesion formation and increased cell adhesion.  One recent, unpublished 
study (Dumbauld, 2013) supports this hypothesis.  The author investigated the of 
vinculin, Vh and T12 (a vinculin autoinhibition mutant; Cohen et al., 2005) expression on 
cellular adhesion, and found that vinculin and Vh increase cellular adhesion 25% over 
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Vcl-null cells, while T12 increases cellular adhesion 50%.   Together, these studies 
suggest that expression of autoinhibition mutants in cells may affect cellular motility by 
affecting how a cell interacts with the extracellular matrix.   
 
The effect of vinculin loss on cell adhesion and migration is typically attributed to the 
presence of vinculin in focal adhesions and vinculin’s ability to modulate the strength 
cell-matrix adhesions, presumably by reinforcement of integrin:ECM connections to the 
actin cytoskeleton.  It should be noted that vinculin is also present at the leading edge of 
migrating cells in nascent focal adhesions and focal adhesion formation itself is 
dependent on polymerization of the actin cytoskeleton causing lamellipodial 
advancement (Choi et al., 2008).  Localized actin polymerization is thought to generate 
and sustain the necessary membrane protrusion of new lamellipodia (Le Clainche and 
Carlier, 2008) where nascent adhesions form (Choi et al., 2008).  Vinculin binds to two 
key proteins in this process, Arp 2/3 (DeMali et al., 2002) and VASP (Brindle et al., 
1996; Reinhard et al., 1996).  The Arp2/3 complex is a key component in regulating 
nucleation of actin polymerization and protrusion at the leading edge of migrating cells 
(Mullins et al., 1998; DeMali et al., 2002) and nucleates actin polymerization by binding 
to the sides of existing cytoskeletal actin filaments (Svitkina and Borisy, 1999), causing 
the formation of the highly branched, dendritic network (Pantaloni et al., 2000; Bailly et 
al., 2001) essential for lamellopodial extension (Bailly et al., 2001).   Vasodilator-
stimulated phosphoprotein (VASP) plays a role in determining actin architecture by 
preventing actin capping and promoting actin elongation (Bear et al., 2002; Barzik et al., 
2005; Pasic et al., 2008).  VASP expression increases the rate of lamellipodial protrusion, 
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but also results in faster lamellipodial retraction, leading to a global negative effect on 
cell motility.  VASP null cells have lamellipodia that protrude more slowly, but persist 
longer (Bear et al., 2002; Krause et al., 2003).  Vinculin’s ability to bind both Arp 2/3 
and VASP provides an alternative mechanism for vinculin to affect cell speed and 
adhesion.  Vinculin could play a role in directing dendritic polymerization and cellular 
protrusion within the cell through its interaction with Arp2/3 and VASP.  This potential 
function of vinculin has not been tested. 
 
Finally, a more recent study indicates that the phosphorylation state of vinculin may 
dictate the timing of vinculin’s turnover within focal adhesions (Kupper et al., 2010).  
From this, one could hypothesize that vinculin’s phosphorylation state may affect cellular 
adhesion and therefore speed.  To date, no studies have been conducted to determine how 
vinculin’s phosphorylation state affects cellular motility.  
 
Evidence for a role for vinculin in force transduction: 
While there is a consistent body of work on the assembly and maturation of focal 
adhesions (DePasquale and Izzard, 1987; Izzard, 1988; Nobes and Hall, 1995; Ezzell et 
al., 1997; Galbraith et al., 2002; Choi et al., 2008; Oakes et al., 2012), the results of 
studies on how external forces affect focal adhesion growth have been less consistent.  A 
number of studies show a positive, linear correlation between increased focal adhesion 
size and increased traction force exerted by the cell onto its growth substrate (Pelham and 
Wang, 1997; Balaban et al., 2001; Beningo et al., 2001; Tan et al., 2003; Goffin et al., 
2006; Stricker et al., 2011), with some studies showing data that there are outlier focal 
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adhesions to this trend (Balaban et al., 2001; Tan et al., 2003; Goffin et al., 2006).  To 
date, there have been five key studies (Riveline et al., 2001; Galbraith et al., 2002; 
Sawada and Sheetz, 2002; Sniadecki et al., 2007; Stricker et al., 2011) on the effect of 
applying external force on focal adhesions.  Each study has used a different approach and 
these studies have had only partially consistent results.  Despite this, the consensus within 
the field has been that the application of external force to cells causes an increase in focal 
adhesion number and size.  It is currently unknown whether external force has different 
effects on focal adhesions in different stages of focal adhesion maturation. 
 
Evidence that vinculin regulates cell survival: 
A single study proposes that an alternative function of vinculin is as a regulator of cell 
viability.  Comparison of parental F9 cells to Vcl-null cells created by EMS mutagenesis 
revealed that Vcl-null cells have increased resistance to apoptosis and that this resistance 
was reversed by expression of vinculin tail.  These findings implied a role for vinculin in 
cell survival.  Further studies showed that Vcl-null cells reduced cleavage of Caspase-9, 
an initiator protease for apoptosis whose cleavage is downregulated by ERK1/2.  
Additional immunoprecipitation studies showed that Vcl-null cells have increased 
paxillin:FAK interaction and increased phosphorylation of paxillin and FAK.  Together, 
Subauste’s findings suggest that a function of vinculin could be to sequester paxillin from 
interacting with FAK, limiting activation of FAK, resulting in lowered activity of 




Use of vinculin mutants to ascertain the role of vinculin in cellular motility and 
mechanotransduction: 
In this thesis, I use wild-type vinculin and a panel of vinculin mutants introduced into a 
previously characterized (Xu et al., 1998a; Xu et al., 1998b) Vcl-null cell-line to study 
the role of vinculin, its autoinhibition, and its specific ligand binding abilities on 1) cell 
speed and 2) the response of mature focal adhesions to external stretch.  My results in 
two different cell systems and two different motility assays show that the expression of 
vinculin has no statistically significant effect on the speed of Vcl-null cells.  In contrast to 
previous studies reporting a difference in cell speed between Vcl-null and vinculin-
expressing cells, my results show that the presence of vinculin is not sufficient to affect 
cellular motility in these cells under the conditions of my experiments.  Furthermore, 
while stretching vinculin-expressing cells can result in impressive changes in mature 
focal adhesion number or size, these changes do not occur with greater frequency in 
stretched cells than in unpaired controls.  A re-examination of the literature in light of 
these results suggests the hypothesis that growth of nascent focal adhesions may be 
responsible for the previously reported findings that application of external force results 
in increased focal adhesion size and suggests an avenue of research that would further 
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Abstract:   
 
Published studies show that vinculin inhibits cellular migration.  Since vinculin has no 
intrinsic enzymatic activity, vinculin’s effect on cell migration is likely mediated by 
vinculin’s interaction with particular binding partners.  Studies have been conducted 
comparing the motility of Vcl-null versus vinculin-expressing cells, and a single study 
has explored how vinculin head and tail domains affect cellular motility.  No studies have 
been performed using vinculin autoinhibition mutants or mutants of full-length vinculin 
that specifically disrupt vinculin-ligand interactions.  Studies using these mutants would 
help clarify the protein:protein interactions involved in vinculin regulated cellular 
motility.  In this study, eGFP-labeled wild-type and mutant vinculin constructs are used 
to test for changes in cellular motility using timelapse microscopy.  My results in two 
different cell systems and two different assays show that the introduction of vinculin into 
Vcl-null cells has no effect on cell speed.  While these results do not agree with the 
majority of published work in the field, these results indicate that the presence of vinculin 
is not sufficient to slow cell speed in assays monitoring the random migration of 




Mutants of vinculin have been developed for a variety of purposes.  Vinculin head (Vh) 
and vinculin tail (Vt) mutants were initially developed to study vinculin head-tail 
interactions and vinculin’s mechanism of autoinhibition (Johnson and Craig, 1994; 
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Johnson and Craig, 1995) before the crystal structure of vinculin had been determined 
(Bakolitsa et al., 2004).  Speculation on the precise intermolecular interactions 
responsible for the tight (10-9 Kd) interface between vinculin head and tail (Bakolitsa et 
al., 2004) prompted the development of two charge-to-alanine mutants that alter sites on 
vinculin head (D4) and vinculin tail (T12) to cause a 100-fold decrease in vinculin’s 
autoinhibition (Cohen et al., 2005).  Other vinculin mutants have been developed that 
ablate binding to VASP (Brindle et al., 1996), Arp 2/3 (DeMali et al., 2002), talin 
(Bakolitsa et al., 2004), and mimic various phosphorylation states of vinculin (Kupper et 
al., 2010).  The Craig lab has created a library of these mutants, each of them fused to 
eGFP (Table 2-1).  Expression of these mutants in Vcl-null cells would clarify how 
vinculin’s autoinhibition and specific ligand binding abilities affect vinculin’s proposed 
functions in cells.   
 
In collaboration with the Garcia lab at the Georgia Institute of Technology, several of 
these eGFP-fused mutants were introduced into a previously characterized Vcl-null 
mouse embryonic fibroblast (MEF) parental line (Xu et al., 1998a) using a tetracycline-
regulated retroviral system.  This strategy has major advantages over a transient 
transfection system in that 1) it eliminates batch-to-batch variability in transfection 
efficiency, 2) the high transduction efficiency of this system results in a polyclonal 
population and eliminates issues found with clonal lines, and 3) tetracycline-regulated 
expression provides ideal negative controls since the eGFP-tagged vinculin mutants can 
be to be turned on or off at will in the same population.  These cell-lines were used in 
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recent studies to show that vinculin and Vh increase cellular adhesion 25% over Vcl-null 
cells, while T12 increases cellular adhesion 50% over Vcl-null cells (Dumbauld, 2013). 
 
Table 2-1:  Reference table of available vinculin mutants, their mutation sites, and altered 
functions.   
 
In this study, I used both cell-lines created with a tetracycline-regulated retroviral system 
and transiently transfected cells to test the effect of vinculin autoinhibition and vinculin 
ligand binding mutants on cell speed.  Cell speed was measured by tracking individual 
cells undergoing random migration and by measuring haptotaxis across a transwell.  
Neither cell system or migration assay reproduced previously published results showing 
Name AA Composition Specific Mutations Comments 
Vin -/- Vcl-null NA Parent Cell Type 
WT GFP: 1-1066 NA Wild Type 
Vh GFP: 1-851 NA Head domain only; 
Does not bind actin 
or paxillin 
D4 GFP : 1-1066 N773;E775:A 100-fold decrease in 
strength of 
autoinhibition 
T12 GFP : 1-1066 D974;K975; 
R976;R978:A 
100-fold decrease in 
strength of 
autoinhibition 
A50I GFP: 1-1066 A50I Blocks binding of 
talin rod domain and 
alpha-actinin 
Arp 2/3 GFP: 1-1066 P878A Blocks Arp2/3 
binding 
VASP GFP: 1-1066 F842A Blocks VASP 
binding 
Y1065E GFP: 1-1066 Y1065E Mimics 
phosphorylated state  





that vinculin slows cell speed.  The tetracycline-regulated retroviral system showed that 
Vh reduces the speed of Vcl-null cells by 14% (p<0.001), but this finding is not 
reproduced with transiently transfected cells.   
 
Materials and Methods: 
 
Cell culture, transduction, and transfection:  Vinculin-null mouse embryonic fibroblasts 
(MEFs) were a gift from Eileen Adamson and have been previously described (Xu et al., 
1998a).  These fibroblasts were engineered to express eGFP-fused vinculin constructs as 
previously described (Dumbauld, 2013).  Stated briefly, these lines were designed with 
the eGFP-fused vinculin constructs downstream of a tetracycline-regulated promoter.  
Incubation of the cell-lines with tetracyline results in repression of construct expression.  
All MEF lines were plated on 0.1% gelatin coated cell culture plastic and maintained 
using high glucose Dulbecco's Modified Eagle Medium (DMEM, Gibco 31053) 
supplemented with 10% FBS (Hyclone) and 2 mM glutamine (Gibco 25030) at 37°C and 
5% CO2.  Cells were enzymatically lifted from the culture dish using 0.04% trypsin 
(Gibco 15090).  For transient transfections, 2x106 cells were combined with 100 uL of 
Ingenio Electroporation Solution (Mirus MIR 50117) and 15 μg of appropriate DNA.  
Cells were electroporated using setting T-20 on an Amaxa electroporation machine.  
Cells were them transferred to RPMI with 10% FBS and incubated for 10 min at 37°C to 
aid membrane closure.  Transfected cells were then transferred to 4 mL of phenol-free, 
high glucose DMEM (Gibco 31053) supplemented with 10% FBS (Hyclone) and 2 mM 




Migration Assay:  2x105 cells were plated on Lab-Tek II Chambered #1.5 Coverglass 
Chambers (Nalge Nunc 155342) coated with 20 μg/μL human plasma fibronectin (Gibco 
33016) diluted in water and blocked with 0.2% BSA.  Cell were allowed to recover for 24 
hrs, and then placed in a microscope incubation chamber (Tokai) at 37°C and 5% CO2.  
Phase contrast or DIC images at 20x magnification were taken using a Nikon Eclipse Ti 
every 2 min for 4 hrs and compiled into films using Nikon Elements software.  Migration 
speeds, cell area, and directional persistence were calculated using either Nikon Elements 
(tetracycline-regulated lines) or Metamorph (transient lines).  The data are expressed as 
the mean values ± SE unless otherwise indicated.  Statistical analysis was performed 
using Kaleidagraph or Graphpad Prism.  A Student t-test was used for two population 
comparisons and a one-way ANOVA was used to compare 3 or more populations.  
p<0.05 was considered to be statistically significant.   
 
Transwell Haptotaxis Migration Assay:  Cells were harvested with 0.4% trypsin (Gibco) 
and plated on 24-well cell-culture inserts containing polyethylene terephthalate 
membrane (PET), 8.0 mm pore size, 1.0x 105 pore density (Corning 3422).  The lower 
surface of the PET membrane was coated with 20 μg/mL human plasma fibronectin 
(Gibco) diluted in Dulbecco's Phosphate-Buffered Saline (DPBS) and then blocked for 30 
min in 0.2% BSA (Sigma 9418) diluted in DPBS that had been heat denatured for 30 min 
at 65°C.  The lower chamber was filled with 1 mL of phenol free DMEM containing 10% 
FBS, and cells were plated in 1 mL of phenol free, serum free DMEM.  Cells were 
allowed to migrate for 8 hrs at 37°C and 5% CO2.  The upper surface of the membrane 
was then wiped with a cotton swab to mechanically remove nonmigratory cells and the 
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migrant cells attached to the lower surface were fixed in 10% formalin at room 
temperature for 30 min, stained for 15min with 0.1% crystal violet in a 100 mM borate 
buffer, pH 9.0, containing 2% ethanol.  The number of stained cells per 20x field were 
photographed and counted.  At least three fields were analyzed per condition per 
experiment.  Background migration was determined using BSA coated PET membranes 




My first experiment compared the speed of the Vcl-null parental cell-line to the virally 
transduced vinculin, Vh, and D4 cell-lines.  The cell-lines were used immediately after 
recovery from freeze down, and plated onto German coverglass chambers coated with 20 
μg/μL fibronectin.  To analyze cell speed, each cell was treated as a single experiment.  
Thirty fluorescent cells from each cell-line were analyzed in each experiment.  The 
results showed no reproducible differences in cell speed between any of the cell-lines 
(Figure 2-2, Experiment 1).  I hypothesized that the lack of speed differences was due to 
the relatively short time (4 hrs) the cells were given to recover between 
trypsinization/plating and filming.  To address this, I repeated the experiment but filmed 
the cells at 4 and 15 hrs after plating.  However, this time both experiments showed 
significant differences in cell speed between the different lines.  The experiment filmed 4 
hrs after plating (Figure 2-2, Experiment 2) showed the Vh-expressing cells move 
significantly more slowly than the other lines, but the expression of vinculin had no effect 
on cell speed.  In contrast, the experiment filmed 15 hrs after plating (Figure 2-2, 
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Experiment 3) showed that expression of Vh had no effect on cell speed, but expression 
of vinculin slowed cell speed.   
 
Because filming the same cell-lines at two different times after plating had resulted in 
conflicting results (Figure 2-2, Experiments 2 and 3), I decided that I needed to determine 
whether the different cell-lines were expressing similar amounts of eGFP-labeled 
construct.  Furthermore, I needed to gain a sense of what proportion of cells in each cell-
line were expressing the eGFP-tagged construct.  I hypothesized that my experiments 
were showing conflicting results because different platings from a single cell-line could 
result in different subpopulations of cells expressing different levels of eGFP-tagged 
construct to be observed.  An initial western blot comparing the expression of eGFP-
tagged vinculin constructs showed there was no expression of eGFP without an attached 
vinculin construct.  However, while the bands for the three vinculin constructs were 
detectable, they showed varying levels of expression (Figure S2-1).  To explore this 
further, I analyzed each cell-line by Fluorescence Activated Cell Sorting (FACS).  This 
showed that each line contained cells that expressed eGFP-tagged constructs over a 
comparable range of fluorescence (Figure 2-1A).  Comparison of vinculin-expressing 
cultures at different passages showed that eGFP fluorescence (and therefore vinculin 
expression) could be lost with continued culture (Figure 2-1B).  Based on this FACS 
data, I decided to FACS sort each cell-line every two weeks for cells expressing 100-
1000 FU.  This would ensure that every cell-line used for future experiments would 
express comparable levels of eGFP-tagged construct.  FACS sorted cell-lines were 
always allowed to recover at least 48 hrs before being used for an experiment. 
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Figure 2-1:  FACS analysis of virally transduced cell-lines to evaluate eGFP-tagged 
construct expression and stability.  Each cell-line was stained with propidium iodide (PI), a 
DNA intercalating agent that marks dead cells.  Live cells have a PI fluorescence between 0-10 
FU.    A) FACS analysis of Vcl-null cells and cells virally transduced with eGFP-tagged vinculin, 
D4 or Vh. The Vcl-null line was eGFP negative and the virally tranduced lines expressed 
comparable levels of eGFP-tagged construct.  B)  Analysis of the vinculin-expressing cell-line 
after time in culture showed that eGFP-expression could be lost with continued passaging.  For 
this reason, each cell-line was FACS sorted every two weeks to maintain eGFP-expression 















After deciding to FACS sort each of my cell-lines to ensure similar expression levels of 
eGFP-tagged constructs, I repeated my random motility assay using FACS sorted cell-
lines and filmed the cells 4 hrs after plating.  There was no speed difference between any 
of the cell-lines (Figure 2-2, Experiment 4).   
 
I hypothesized that the motility phenotype was still not being observed because I had 
FACS sorted the cell-lines for inappropriately high expression levels of eGFP-tagged 
construct (100-1000 FU).  I resorted the cell-lines for cells 50-100 FU.  These cell-lines 
became infected from the FACS sorting process. After consultation with my laboratory, I 
decided to treat these cells with a combination of penicillin, streptomycin, and 
gentamycin for 12 hrs.  I then filmed the lines 4 hrs and 15 hrs after plating.  Neither 
experiment showed significant differences in cell speed between the various lines (Figure 
2-2, Experiments 5 and 6).   
 
I attempted two final random motility experiments using these lines.  The cells were 
again FACS sorted for between 100-1000 FU, and I decided to revisit the effect of time 
after plating on cell speed using the FACS sorted cell-lines.   The experiment filmed 4 hrs 
after plating showed no differences in cell speed between the lines (Figure 2-2, 
Experiment 7).  The experiment filmed 15 hrs after plating showed that expression of 
vinculin increased cell speed (Figure 2-2, Experiment 8).  This was in conflict with the 
effect of vinculin expression observed in Experiment 3 (also taken 15 hrs after filming) 
and opposite to the trend published in the literature.   
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In total, thirteen experiments comparing the transduced cell-lines were completed (Table 
S2-1). I have described eight in detail in this manuscript, and they are summarized in 
Figure 2-2.  Two additional experiments were completed using cells that had not been 
FACS sorted.  These experiments were conducted because there was a period of time 
when our lab did not have access to a FACS sorting facility.  I chose not to analyze this 
data because FACS analysis of my cell-lines showed that expression of eGFP-tagged 
constructs could decrease with continued passage (Figure 2-1B), and I could not be 
confident the cells were expressing similar levels of eGFP-tagged constructs during those 
experiments.  I also completed two experiments where I worked briefly in collaboration 
with both the Garcia lab and Intelligent Substrates™ to test different potential coatings 
for the German coverglass chambers.  The Garcia lab suggested modifying the protocol 
to coat the chambers with fibronectin to match their protocol for fibronectin coating that 
had been previously established for use in their various cell adhesion studies (Michael, 
2003).  Briefly, German coverslips are first coated by successive thin films of titanium, 
and gold, and then incubated with hexadecanethiol (HDT) followed by human plasma 
fibronectin.  In collaboration with the Garcia lab, the chambers were treated to create a 
thin film of titanium and gold, and then subsequently incubated with HDT and 
fibronectin in the Craig lab.   Our cell-lines began apoptosis within 4 hrs after being 
plated on this substrate and did not survive long enough to be filmed.  Additionally, we 
worked in collaboration with Intelligent Substrates™ to determine whether using a 
proprietary method for patterning the fibronectin growth substrate would limit the 
direction of cellular motility and result in differences in cell speed.  The cell-lines 
tolerated these patterned substrates initially, but apoptosed during the course of filming.  
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Since we had been able to successfully culture the transduced cell-lines using the 
fibronectin coating protocol established in the Craig lab, these alternative coating 























Figure 2-2:  Eight experiments comparing the random migration speed of Vcl-null cells to 
cell-lines expressing different eGFP-tagged vinculin constructs.  Vcl-null MEF cells virally 
transduced with eGFP-tagged constructs for vinculin, Vh, and D4 were plated on fibronectin-
coated german coverglass chambers.  To determine the effect of filming at different timepoints 
after plating, Experiments 1, 2, 4, 5, and 7 were filmed 4 hrs after plating and  Experiments 3, 6, 
and 8 were filmed 15 hrs after plating.  FACS sorting ensured comparable expression levels of 
eGFP-tagged construct between cell-lines.  Experiments 3, 4, 7, and 8 were FACS sorted for 
cells between 100-1000 FU.  Experiments 5 and 6 were FAC sorted for cells between 50-100 FU.  
For filming, the chambers were moved to an onstage incubator and imaged using 20x DIC or 
Phase objectives.  The resulting films were analyzed by tracking the nucleus of 30 GFP-positive 
cells from each cell-line every 2 min over 4 hrs using Nikon Elements tracking software.  The 
resulting data was analyzed by ANOVA.  Red line indicates average cell speed.  * implies p<0.01, 
















































Of my timelapse films, eight experiments contained 4 hrs of motility data on healthy, 
fluorescent cells.  I decided to pool the data from these experiments, treat each cell as an 
experiment in cellular motility, and determine whether the larger sample number and 
increased statistical power would detect small differences in cell speed between the lines.  
Pooling the data showed a small (36.6 μm/hr versus 31.9 μm/hr) speed difference 
between Vcl-null cells and the Vh cell-line (Figure 2-3).  However, there was no speed 
difference between Vcl-null and vinculin-expressing lines.  This result was not in 
agreement with previous publications showing that vinculin expression slows cell speed 






























Figure 2-3:  When the data from 8 individual experiments is pooled, there is no speed 
difference between Vcl-null and vinculin-expressing cells.  Vcl-null MEF cells virally 
transduced with eGFP-tagged constructs for vinculin, Vh, and D4 were plated on fibronectin-
coated german coverglass chambers and allowed to recover at least 4 hrs.  The chambers were 
then moved to an onstage incubator and imaged using 20x DIC or Phase objectives.  The 
resulting films were analyzed by tracking the nucleus of 30 GFP-positive cells from each cell-line 
every 2 min over 4 hrs using Nikon Elements tracking software.  The resulting pooled data was 



















The inability to reproduce previously published differences in cell speed prompted me to 
study whether the substrate extracellular matrix (ECM) concentration affected cell speed.    
Palecek et al. had shown that CHO cells have a biphasic migration speed dependence on 
substrate fibronectin concentration.  At low fibronectin concetrations, cell speed 
increased as fibronectin concentration on the substrate increased.  However at high 
fibronectin concentrations, cell speed decreased as fibronectin concentration on the 
substrate increased (Palecek et al., 1997).   Our collaborators in the Garcia lab had 
preliminary data that the adhesiveness of our construct lines changed with fibronectin 
concentration.  Additionally, I conducted a preliminary enzyme-linked immunosorbent 
assay (ELISA) to analyze the adsorption of fibronectin to the German coverglass 
chambers used in my assays.  This ELISA data showed that incubation of the German 
coverglass chambers with 20 μg/mL fibronectin was near saturating while incubation of 
the German coverglass chambers with 5 μg/mL fibronectin reduced fibronectin binding 
67% (data not shown).  Based on this information, I hypothesized that my experiments 
were conducted at a saturating concentration of fibronectin (20 μg/ml) that limited cell 
speed and prevented detection of speed differences between the different cell-lines.  To 
address concerns about whether the amount of fibronectin bound to the coverslips was 
responsible for the lack of motility differences observed between the virally transduced 
cell-lines, I conducted another random migration experiment where cell speed was 
analyzed at two different concentrations of fibronectin, 20 μg/mL and 2 μg/mL.  
Lowering the concentration of fibronectin used to coat the growth substrate increased 
overall migration speed, but this increase was not significant.  Lowering the 
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concentration of fibronectin did not result in speed differences between Vcl-null and 





























Figure 2-4:  Substrate fibronectin concentration has no effect on cell speed.  Vcl-null and 
vinculin-expressing cells were plated onto German coverglass chambers coated with either 
saturating (20 μg/mL) or minimal (2 μg/mL) fibronectin and allowed to recover for 48 hrs.  Cells 
were filmed as described above with images collected every 6 min for 5 hrs.   The resulting films 
were analyzed by tracking the nucleus of 30 GFP-positive cells from each cell-line every 6 min 
over 5 hrs using Nikon Elements tracking software.  The resulting data was analyzed by ANOVA.  
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Although two studies have been published (Mierke et al., 2010; Fraley et al., 2010) that 
analyze random cell motility, the majority of studies on vinculin’s effect on cell 













(Table 1-1).  To determine whether the assay itself was the cause for not being able to 
replicate results published in previous studies, I used the virally transduced lines in a 
haptotaxis assay on transwells.  An initial experiment did show a significant difference in 
migration between Vcl-null and vinculin-expressing cells.  However, this migration was 
not a fold change as previously reported (Xu et al., 1998a; Xu et al., 1998b; DeMali et 
al., 2002).  Furthermore, this small but significant difference in cell speed between Vcl-



















Figure 2-5:  An initial small but significant migration differences between Vcl-null and 
vinculin- expressing cells.   Polyethylene terephthalate (PET) transwells were coated with 
either 20 μg/mL BSA (BSA) or 20 μg/mL fibronectin (FN).  Vcl-null or vinculin-expressing cells 
were plated on the transwell, allowed to migrate through transwell for 8 hrs, fixed with 
paraformaldehyde, and stained with 0.1% crystal violet.  For each experiment, three 20x fields 
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While my data did not show differences in cell speed between Vcl-null and vinculin-
expressing cells, it was still possible that there were gross morphological differences 
between Vcl-null and vinculin-expressing cells.  Previously published data shows that 
Vcl-null F9 cells have decreased cell area compared to wild-type F9 cells (Xu et al., 
1998b).  To determine whether vinculin expression affected the average cell areas of the 
different virally transduced cell-lines, I randomly selected two of the previously collected 
timelapse microscopy experiments (Experiment 2 and Experiment 6) and reanalyzed the 
images to quantify cell area.  Thirty cells from each cell-line were analyzed from each of 
these experiments, and the two experiments show similar trends in relative cell area. 
When the data was pooled across the two experiments, Vcl-null cells were found to be 
significantly smaller than any other cell-line studied (Figure 2-6).  There was no 
difference in area between any of the lines expressing eGFP-labeled constructs.  
However, it should be noted that the negative control in these experiments, the parental 
Vcl-null MEFs, had not undergone the viral transduction process.   Early discussions 
between our lab and the lab of our collaborator’s had decided that the Vcl-null line would 
be an adequate initial negative control.  The data in Figure 2-6 caused me to revisit how I 









Figure 2-6:  The parental Vcl-null MEFs have a consistently smaller cell area than all the 
cell-lines created with virally transduced vinculin constructs.  Two previously collected 
timelapse experiments were reanalyzed to quantify the cell area of 30 GFP-positive cells in each 
cell-line.  The data for the two experiments was pooled for statistical analysis.  Each bar 
represents the mean area of 60 cells from two experiments. Analysis of the resulting data by 
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Since the only area differences occurred between the parental Vcl-null cell-line and 
virally transduced cell-lines, I began to question whether the parental Vcl-null cells were 
the appropriate negative control for my experiments.  At this point, I decided to use the 
fact that the virally transduced lines were originally designed to allow tetracycline 
regulation of eGFP-construct expression to determine whether, in these cell-lines, Vcl-
null cells have decreased cell area compared to cells expressing eGFP-tagged vinculin or 
eGFP-tagged vinculin mutants.  Failure to reproduce my previous results showing that 
Vcl-null cells were significantly smaller than any other cell-line studied (Figure 2-6) with 
paired, tetracycline-regulated lines would indicate that the finding was due the parental 
Vcl-null cell-line being an inappropriate negative control for my previous experiments.  
Furthermore, it would stand as evidence that I should instead move towards a transient 
transfection system.   
 
Prior to my joining the Craig lab, our collaborators in the Garcia lab had sent a library of 
cell-lines that had been virally transduced to have tetracycline-regulated expression of 
wild-type eGFP-vinculin and eGFP-tagged vinculin mutants.   Each virally transduced 
cell-line used in this study was created with the eGFP-tagged vinculin construct 
downstream of a tetracycline-downregulated promoter.  Culture of the virally transduced 
cell-lines in 10ng/mL tetracycline should repress expression of the eGFP-tagged 
constructs (Dumbauld, 2013).  Therefore, treatment with tetracycline allows creation of a 
matched Vcl-null control cell-line for every virally transduced cell-line.  To date, I had 
only used three of these lines (vinculin, D4, and Vh).  Conversations with the Garcia lab 
had indicated that two of these lines were not able to be tetracycline-regulated:  vinculin 
and D4.   
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Since I was going to invest the effort to create paired, tetracycline lines, I decided to 
examine the entirety of the cell-line library for the effect of vinculin and vinculin mutants 
on cell area.  This would allow me to work with a new mutant of vinculin (A50I) as well 
as provide a cell-line containing a vinculin autoinhibition mutant (T12) that (according to 
the Garcia lab) could be tetracycline-regulated.   FACS analysis of the A50I and T12 
lines showed that these lines had similar baseline fluorescence to previously studied cell-
lines (Figure 2-7a).   
 
To provide a paired Vcl-null control for the vinculin line (which, according to the Garcia 
lab, could not be tetracycline-regulated), I purposefully FACS sorted GFP negative cells 
from the vinculin-expressing line.  These cells were cultured as a separate line named 
“Vcl-null 2”.  These cells were maintained in culture for three weeks and showed no 
expression eGFP vinculin when analyzed three weeks later (Figure 2-7a).  The Vcl-null 2 
line would also allow me to test whether eGFP-fluorescence was truly linked to vinculin 
expression in the virally transduced lines.  Vcl-null 2 cells should not contain 
tetracycline-regulated eGFP-tagged vinculin construct.  Therefore, they should be 
resistant to any effects of tetracycline treatment.   
 
Four cell-lines were initially treated with 10ng/mL tetracycline to determine by Western 
blot whether expression of the eGFP-tagged vinculin constructs could be repressed.  As 
expected, the vinculin-expressing line showed no change with treatment.  Treatment of 
the Vh-expressing and T12-expressing lines showed undetectable levels of eGFP-tagged 
protein by 7 days of treatment (Figure 2-7b).  Based on conversations with the Garcia lab, 
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I did not test the regulation of the A50I and D4 cell-lines by Western blot.  Instead, I 
considered the A50I cell-line tetracycline-regulated and the D4 cell-line incapable of 
tetracycline regulation.  I then created paired cell-lines for every eGFP-tagged vinculin 
construct.  To create negative controls (Tet +), each virally transduced line was treated 
with 10ng/mL tetracycline for at least 16 days to achieve maximum repression of 
construct expression.   To ensure that construct-expressing cell-lines (Tet -) would 
continue to express comparable levels of fluorescence for future experiments, I continued 


















Figure 2-7:  Testing the effect of vinculin and vinculin mutants on cell area required the 
use of additional cell-lines and testing the tetracycline regulation of the virally transduced 
lines.  A) The A50I and T12 lines showed comparable levels of baseline fluorescence to 
previously studied virally transduced cells lines. The T12 line provided a virally transduced line 
expressing a tetracycline-regulated autoinhibition mutant of vinculin.  The Vcl-null 2 line isolated 
from the eGFP-vinculin line by FACS sorting showed no signs of spontaneous eGFP-vinculin 
expression 3 weeks after isolation.  These cells were subsequently used as a negative control for 
the eGFP-vinculin line.  B) The parental Vcl-null, vinculin, Vh, and T12 cell-lines were treated with 
10ng/mL tetracycline. “Day” indicates the number of days the cells were treated with tetracycline.  
“Tet” indicates the presence or absence of tetracycline.  The vinculin-expressing line is not 
regulated by tetracycline treatment.  The Vh and T12 lines show undetectable levels of eGFP-












All the construct-expressing lines and their paired negative control cell-lines were plated 
and imaged as described above.  Two experiments were completed, and for each 
experiment thirty cells were analyzed for each cell-line.  Since the trends in each 
individual experiment were similar, the data collected from the two experiments was 
pooled to give a larger sample number and increased statistical power.  Of the cell-lines 
that could be tetracycline-regulated (A50I, Vh, and T12), only the Vh-expressing line 
showed a greater average cell area than its tetracycline-downregulated negative control 
(p=0.001) (Figure 2-8).  This indicated that my previous findings (Figure 2-6) were likely 
the result of the parental Vcl-null cell-line being an inappropriate negative control for the 
virally transduced cell-lines.  More significantly, the GFP-negative cells that had been 
FACS sorted from the vinculin line (Vcl-null 2) showed significant (p=0.002) changes in 
cell area with tetracycline treatment (Figure 2-8).  This indicated that there was a 
disconnect between tetracycline regulation and eGFP-construct expression in these 












Figure 2-8:  Providing the virally transduced cell-lines with individual negative controls 
ablated most differences in cell area.  Two experiments were conducted using all the 
construct-expressing lines and their paired negative control cell-lines.  Cells from each line were 
plated and filmed as previously described.  For each experiment, 30 GFP-positive cells were 
analyzed for total cell area using Nikon Elements.  The two separate experiments showed similar 
trends, so the data was pooled to increase sample number and statistical power.  Each bar 
represents the average area of 60 analyzed cells for each condition.  Solid bars indicate cell-lines 
expressing the construct listed.  Bars with a hash mark pattern indicate the tetracycline treated 
paired control cells lines.  Vcl-null 2 is a line created by FACS sorting the eGFP-vinculin-
expressing line (Vinculin).  Error bars indicate S.D.  Data was analyzed by ANOVA.  Of the lines 
that could be regulated (A50I, Vh, and T12), only the Vh-expressing line showed a greater 
average cell area than its tetracycline-downregulated negative control (p=0.001).  The Vcl-null 2 
cells should contain no tetracycline-regulated eGFP-vinculin construct but show significant 
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Overall, using the paired, tetracycline-regulated lines showed me that my previous data 
showing that vinculin and vinculin mutants affect cell area were likely only due to an 
inappropriate negative control.  Furthermore, this data indicated that I would have to 
address the caveat of using separate cell-lines to test phenotypic differences between Vcl-
null and vinculin-expressing cells:  Separate cell-lines, despite being generated from the 
sample parental cell-line, can diverge from each other when maintained separately in 
culture.  As a result, attempts to compare phenotypic differences between the cell-lines 
may reflect differences between the lines that result from divergence and not from the 
expression of different eGFP-tagged constructs.   
 
The caveats of using separate cell-lines to test for speed differences between Vcl-null 
cells and cells expressing various eGFP-tagged constructs could be addressed in several 
ways.  One option would be to use the parental line as a negative control.  However, my 
data shows that attempting to use the parental Vcl-null cell-line as a negative control does 
not produce the previously published result that expression of vinculin decreases cell 
speed.  Another option would be to create a negative control cell-line by virally 
transducing the parental Vcl-null cell-line with an empty vector.  Our collaborators in the 
Garcia lab attempted to virally transduce the parental Vcl-null cell-line with an empty 
vector but were not successful.  Additionally, one could test multiple versions of each 
cell-line to ensure that observed phenotypic differences are dependent on the construct 
being expressed and not on divergence of the cell-lines being studied.  However, this 
results in the need to maintain an onerous number of cell-lines.  Finally, one could 
attempt to knockdown expression of endogenous vinculin with siRNA before expressing 
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the desired eGFP-tagged construct.  However, previous studies in the Craig lab 
(unpublished data) showed that while siRNA attempts can significantly reduce vinculin 
expression levels on Western blot, the vinculin that is expressed in cells transfected with 
siRNA constructs against vinculin localizes to focal adhesions.  Based on these options, 
and previous attempts to created alternative negative controls for vinculin expression in 
both the Craig lab and the Garcia lab, I decided that I would stop using the virally 
transduced cell-lines and repeat the random motility assays using transiently transfected 
cells.   
 
One final experiment was conducted to confirm the presence of systemic errors in the 
virally transduced cell-lines.  Timelapse microscopy was performed to compare cell 
speed between the vinculin line and the line obtained by FACS sorting the vinculin line 
for GFP-negative cells (Vcl-null 2).  Thirty cells from each line were analyzed and there 












Figure 2-9:  A virally transduced vinculin-expressing lines compared to the most 
appropriate negative control failed to produce expected speed differences.  The vinculin 
line and the line obtained by FACS sorting the vinculin line for GFP-negative cells (Vcl-null 2) 
were imaged as described above to determine the comparative cell speed of these cell-lines 
during random migration.  The resulting film was analyzed by tracking the nucleus of 30 GFP-
positive cells from each cell-line every 2 min over 4 hrs using Nikon Elements tracking software.  
The resulting data was analyzed by ANOVA.  Red line indicates average cell speed.   There was 









                                              Vinculin                  Vcl-null 2 
   





















Since the virally transduced cell-lines had failed to produce a vinculin-dependent cell 
speed phenotype and since there was evidence that the tetracycline regulation in these 
lines was questionable, I deemed transient transfection necessary for any further studies 
on the effect of vinculin on cellular motility.  Originally, transient transfection had been 
avoided because Vcl-null MEFs have a particularly low transfection rate of 1-2% using 
conventional lipofectamine.  However, I was able to develop an electroporation protocol 
that had sufficient transfection efficiencies (20% - 40%) and the motility studies were 
repeated.   
 
Five experiments using transiently transfected cells were conducted (Figure 2-10).  The 
culture, plating, and microscopy conditions were identical to those described previously.  
As a negative control, Vcl-null cells were underwent an “empty transfection”, i.e. they 
were electroporated in solution lacking a construct.  There was no speed difference 
between empty transfections and cells that had been transiently transfected with eGFP 
alone (Figure 2-10, Experiment 1).  There were no differences in cell speed between the 
negative controls and cells expressing any vinculin construct.  However, the difficulty in 
transfecting certain constructs lead to small sample numbers in individual experiments.  
For this reason, the data was pooled to yield larger sample numbers and increase 
statistical power.  The pooled data also showed no difference in cell speed between the 









Figure 2-10:  Cells transiently transfected with different eGFP-vinculin mutant constructs 
showed no difference in cell speed compared to negative controls.  Vcl-null cells were 
transiently transfected with eGFP-tagged vinculin or vinculin mutant constructs, then plated and 
filmed as described above.  As a negative control, Vcl-null cells were underwent an “empty 
transfection”, i.e. they were electroporated in solution lacking a construct.  Data on cell speed was 
analyzed by ANOVA.  Red bars indicate average cell speed.  Over five experiments, each 
evaluating slightly different groups of constructs, there was no difference in cell speed between 























































Figure 2-11:  Pooled data across all transient transfection experiments show that the 
presence of vinculin, or any of its mutants, has no effect on cell speed.  Vcl-null cells were 
transiently transfected with eGFP-tagged vinculin or vinculin mutant constructs, then plated and 
filmed as described above.  As a negative control, Vcl-null cells underwent an “empty 
transfection”, i.e. they were electroporated in solution lacking a construct.  “Double Mutant” is a 
construct containing both the Arp2/3 and VASP mutations. Data on cell speed was analyzed by 
ANOVA.  Red bars indicate average cell speed.  There were no differences in cell speed between 






                                                




















I began this study hoping to use virally transduced cell-lines expressing eGFP-tagged 
vinculin constructs to explore the effect of vinculin, its autoinhibition, and its ligand 
binding abilities on cell speed.   These cells lines had been created in collaboration with 
the Garcia lab to have the eGFP-tagged constructs downstream of a tetracycline-
downregulated promoter.  Ideally, these lines could be treated with tetracycline to create 
a paired negative control cell-line.  I also anticipated that they would be a superior system 
for generating a high level of reproducibility between experiments not achievable through 
transient transfection.   
 
Prior to beginning my experiments, the Garcia lab had collected preliminary data that the 
vinculin and D4 lines were not under complete regulation by the tetracycline-
downregulated promoter.  They were, at the time, still trying to generate tetracycline-
regulated lines for eGFP alone, eGFP-tagged vinculin, and eGFP-tagged D4.  For this 
reason, after several discussions with both my lab and the Garcia lab, I decided to use the 
parental line used to create each of these cell-lines, Vcl-null MEFS from the Adamson 
lab, as negative control for my experiments.  Figures 2-6, 2-8, and 2-9 together indicate 
that there is a distinct difference between using the parental line as a negative control and 
using a negative control that had been created by tetracycline downregulation of construct 
expression.    When using the Vcl-null MEF parental line as a negative control, I found 
that vinculin, D4, and Vh had no effect on cell speed but significantly increased cell area.  
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These differences did not reproduce when a paired, tetracycline-downregulated negative 
control was created for each cell-line.    
 
Despite these systemic and technical issues, this study did gather a large amount of data 
regarding the effect of vinculin on cellular motility.  Since I used timelapse microscopy 
instead of population migration studies, I could treat each analyzed cell as an experiment 
on how the expression of a particular vinculin construct effects random motility.   
However, despite large sample numbers (Figure 2-3), I did not observe the previously 
reported finding that vinculin-expressing cells have a slower migration speed than Vcl-
null cells (Table 1-1).  Despite this, I do feel confident that these engineered lines are able 
to report phenotypic differences due to the expression of vinculin or its mutants.  Our 
collaborators in the Garcia lab were able to use these lines to detect adhesion differences 
between cells expressing vinculin, Vh, and T12.  However, the parental Vcl-null MEFs 
line served as the negative control in many of their experiments (Dumbauld, 2013).  I 
have interpreted this to indicate that while the lines created were appropriate for the 
adhesion studies used in that paper, they were not appropriate for timelapse migration 
studies. Furthermore, I am confident that any shortcomings of the engineered lines were 
addressed when my experiments were repeated using transiently transfected Vcl-null 
MEFs (Figures 2-10 and 2-11) derived from vinculin null mouse embryos and wild type 
littermates.    
 
A critical review of previous studies comparing the motility of Vcl-null to vinculin-
expressing cells reveals that the majority of these studies were population migration 
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studies.  There are only two published studies that use timelapse microscopy of individual 
cells instead of population migration studies.  These studies had conflicting results.  
While Mierke (Mierke et al., 2010) confirmed previous results showing a 3-fold speed 
difference, Fraley (Fraley et al., 2010) reports no speed difference at all.   I interpret these 
studies, in addition to my own, as indicating that the actual effect of vinculin on cell 
speed may not be dependent on its role in adhesiveness and that timelapse photography 
highlights this in a way that population studies do not.   Although, if that were the case, I 
expect to have had similar results to previously published studies in at least in my 
haptotaxis assays (Figure 2-5).  Additionally, only a single published study attempts to 
rescue a Vcl-null line with expression of a vinculin construct (Xu et al., 1998b).  In this 
study, the author published an image of a single haptoxis field that was analyzed in her 
study and states the expression of vinculin in Vcl-null cells decreased cell speed.    There 
is no quantitation of the data presented.  The remaining studies (Table 1-1) compare the 
relative cell speeds of separate cell-lines.  After a review of my data and the conditions of 
previously published studies on the effect of vinculin on cell speed, I hypothesize that 
there is a difference in motility that is present in primary lines or newly immortalized 
Vcl-null lines that has been lost in my Vcl-null cells with passage.  I have not repeated the 
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Chapter 2 Supplementary Information: 
 
 
Figure S2-1:  An initial Western blot comparing the expression levels of eGFP-constructs 
in the virally transduced cell-lines.  Lanes are as follows:  1) eGFP alone 2) Benchmark ladder 
3) eGFP-Vh line 4) eGFP-vinculin line 5) eGFP-D4 line 6) Vcl-null parental line  This image is a 
scanned reproduction of a printed image.  The scanned image was imported into Photoshop and 
converted to black and white.  Western blot samples were prepared by lysing 2x107 cells from 
each line in 500 uL of lysis buffer.  5 uL of this sample was run a 4-12% Bis-Tris gel and 
transferred to nitrocellulose.  Antibodies: eGFP (C22, 1:2000), actin (C4, 1:4000).  The Vh, 
vinculin, and D4 lines all express eGFP-labelled vinculin construct, but at varying levels.  No 









Table S2-1:  Summary of all motility experiments conducted.  Thirteen experiments 
comparing the cell speed of the virally transduced cell-lines were completed.  “a” indicates a film 
taken 4 hrs after plating cells and “b” indicates a film taken 15 hrs after plating cells.  Small 
changes in experimental conditions were made with each experiment (described in detail in the 
text) to determine if there were technical reasons I was not able to reproduce previously 
published differences in the cell speeds of Vcl-null versus vinculin-expressing cells.  As no single 
experiment was able to do this, each experiment that filmed cells every 2 min for at least 4 hrs 
was analyzed both individually and included in a pooled analysis (Figure 2-2 and Figure 2-3).  
These experiments are marked “Yes” in the Data Analyzed column and are listed as Experiments 


























 vin -/- WT Vh D4     
8/20/09 x x x x No Good Yes 
No differences in average speed.  Vcl-null line has a 
greater distribution of velocities 
9/15/2009a x x x x No Good Yes Vh significantly slower 
9/15/2009b x x x x No Good Yes 
Vcl-null has a smaller spread in cell speeds.  Vinculin-
expressing slowest, then Vh. 
10/22/2009b x x  x Yes Good Yes 
FACS sorted for 100-1000 FU. No differences in 
average cell speed. 
11/6/2009a x x x x No* Good No 
Film not analyzed.  Cells FACS analyzed but not sorted 
and microscope’s fluorescent bulb broken. 
11/6/2009b x x x x No* Good No 
Film not analyzed.  Cells FACS analyzed but not sorted 
and microscope’s fluorescent bulb broken. 
11/16/2009a x x x x Yes Poor No 
Garcia lab HDT substrate.  Cells are spiky and many 
die during filming.  Film not analyzed. 
11/16/2009b x x x x Yes Not ideal No 
Garcia lab HDT substrate.  Cells more spiky than usual 
and have low motility.  Film not analyzed. 
11/20/09 x  x x No Good No 
Biowrite (Intelligent Substrates™) substrate.  Cells 
initially looked healthy but died during filming.  Film not 
analyzed. 
12/3/2009a x x x x Yes Good Yes 
FACS sorted for 50-100 FU.  Cells infected and grown 
for 12 hrs in Pen/Strep/Gent. Experiments conducted in 
Pen/Strep. Occasional Vh cell is blebby. 
12/3/2009b x x x x Yes Poor Yes 
FACS sorted for 50-100 FU.  Cells infected and grown 
for 12 hrs in Pen/Strep/Gent.  Experiment conducted in 
Pen/Strep.  All lines contain a few blebby cells. 
12/4/2009a x x  x Yes Not ideal Yes 
FACS sorted for 100-1000 FU. Cells infected and 
grown for 24 hrs in Pen/Strep/Gent.  Experiment 
conducted in Pen/Strep/Gent.  A few blebby cells in all 
lines, but fewer than on 12/3/2009. 
12/4/2009b x x  x Yes Good Yes 
FACS sorted for 100-1000 FU. Cells infected and 
grown for 24 hrs in Pen/Strep/Gent.  Experiment 
conducted in Pen/Strep/Gent.  A few blebby cells in all 




                           




A Simple Benchtop Device to Study the Effects of Acute 



























Studies showing a positive correlation between the size of a focal adhesion and the 
traction force exerted by that focal adhesion on the cell substrate prompted questions 
about how focal adhesions would respond to the application of external force.  Over the 
last decade, several studies have tried various approaches to applying external force to 
living cells.  The methods and results have been varied, but together they have led to the 
consensus within the field that the application of external force to living cells leads to an 
increase in focal adhesion size.  In order to determine the role of vinculin, its 
autoinhibition, and its ligand binding abilities on the focal adhesion response to external 
force, I developed a simple, manual device capable of applying uniaxial stretch to living 
cells.  I then applied acute, uniaxial stretch to living cells expressing two markers of focal 
adhesions:  vinculin and paxillin.  Surprisingly, while stretched cells could show 
impressive changes in focal adhesion size and number, I found that these changes did not 
occur with greater frequency in stretched cells than in unpaired timelapse controls.  This 
result prompted me to examine published studies on the effects of external force on living 
cells for conditional aspects of the assays that might explain why I could not produce the 
expected result of uniaxial stretch causing increased focal adhesion size.  In doing so, I 
found evidence that previous studies may have been conducted under conditions that 
weigh the observations toward the effect of external force on the growth of nascent focal 
adhesions.  Furthermore, I did not find a single study that was conducted to parse how the 
application of external force affects nascent versus mature focal adhesions.  In light of 
this information, I hypothesize that external force may have different effects on different 
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populations of focal adhesions.  Furthermore, I believe that my data is in accordance with 
two more recent studies indicating that established focal adhesions respond differently 
than nascent focal adhesions to external force.  My assay, with several clearly described 
modifications, could in the future be used to determine the effects of external force on 
different populations of focal adhesions.  Once such a study is completed, then one would 






















Studies characterizing the interaction between cells and their substrates led to the 
discovery that cells are capable of exerting traction forces upon their substrates.  Cells in 
culture are capable of generating traction forces sufficient to cause gross deformation of 
rubber or collagen artificial substrates (Harris et al., 1981; Stopak et al., 1985; Lee et al., 
1994; Oliver et al., 1995).  In vivo, the cells of a developing embryo exert sufficient 
traction forces to rearrange injected, fluorescently labeled collagen according to the needs 
of developing embryo (Stopak et al., 1985).   More recent advances in microfabrication 
and imaging technology have allowed analysis of how individual focal adhesions 
generate traction forces.  These studies have shown that cells can sense the rigidity of 
their growth substrate (Pelham and Wang, 1997) and increase focal adhesion number and 
size in response to increased substrate stiffness (Pelham and Wang, 1997; Choquet et al., 
1997).  Subsequent research quantifying the traction forces exerted by individual focal 
adhesions on a cell’s growth substrate has led to the consensus within the field that 
increasing traction force upon a substrate is correlated with increasing focal adhesion size 
(Beningo et al., 2001; Balaban et al., 2001; Tan et al., 2003; Goffin et al., 2006).  
However, there is evidence that the relationship between focal adhesion size and traction 
force is complex.  Very small (Tan et al., 2003) and very large focal adhesions have been 
shown to exert traction forces disproportionate to their size (Goffin et al., 2006).  
Furthermore, locomoting cells show an inverse relationship between traction force and 
focal adhesion length at the leading edge of cells, but not in their retracting tails (Beningo 
et al., 2001).  Clearly, how a cell modifies focal adhesions to generate various traction 
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forces, and what dictates the strength of traction forces generated, has not been 
completely parsed.  However, studies on the maturation of focal adhesions indicate that 
myosin II-dependent contractility is necessary for focal adhesion growth (Riveline et al., 
2001; Choi et al., 2008).  To mimic cellular contractility, several studies have 
intentionally applied force to living cells to study the focal adhesion response to external 
force.   These studies have used the focal adhesion proteins vinculin (Riveline et al., 
2001; Galbraith et al., 2002; Sniadecki et al., 2007) and paxillin (Sawada and Sheetz, 
2002) as reporters of focal adhesion growth and provided evidence that there is also a 
correlation between applied external force (as opposed to traction force) and focal 
adhesion size.  While each study used slightly different methods and had slightly varied 
results, together these studies have led to the consensus within the field that application 
of external force to cells results in increased focal adhesion size.    
 
Vinculin could potentially play a role in regulating traction forces.   Vinculin is recruited 
early in the process of focal adhesion maturation (DePasquale and Izzard, 1987; Izzard, 
1988; Ezzell et al., 1997; Choi et al., 2008) and could potentially regulate the assembly 
of new adhesions.  Since one of vinculin’s proposed functions within a cell is to act as a 
mechanical linker between the cytoskeleton and the extracellular matrix, a role for 
vinculin in regulating the focal adhesion growth and traction forces would provide a 
mechanism for mechanosensing in focal adhesions.   
 
This potential role for vinculin is supported by data generated using Vcl-null cells.  Loss 
of vinculin in most cells decreases lamellipodial protrusion (Rodriguez Fernandez et al., 
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1993; Xu et al., 1998; DeMali et al., 2002), decreases focal adhesion size (Rodriguez 
Fernandez et al., 1993; Xu et al., 1998), and decreases overall cell adhesion (Xu et al., 
1998; Dumbauld, 2013), while increasing cell speed (Table 1-1).  Since cellular motility 
is dependent on the strength of adhesions generated between the cell and the extracellular 
matrix (Palecek et al., 1997), together these findings indicate that cellular motility may be 
partly regulated by altering cellular traction forces through focal adhesions.  These 
studies also indicate that information on how the autoinhibition and ligand binding 
abilities of vinculin affect focal adhesion responses to external force would illuminate 
how vinculin regulates cell adhesion and motility.  Previous studies have shown that 
expression of vinculin autoinhibition mutants (Cohen et al., 2005; Humphries et al., 
2007) or VD1 increase focal adhesion size and number.  It has also been shown that 
autoinhibition mutants of vinculin increase cellular adhesion (Dumbauld, 2013).  
However, no study has expressed vinculin autoinhibition or ligand binding mutants in 
cells to ascertain their effect on how focal adhesions respond to external force.   
 
In this study I first develop a simple, manually operated device to apply uniaxial stretch 
commercial, silicone-based cell culture chambers.  After characterization, the device is 
used to apply acute, uniaxial stretch to cells expressing YFP-Paxillin, eGFP-vinculin, or 
eGFP-Vh.  Despite each focal adhesion marker showing instances of marked focal 
adhesion change in stretched cells, analysis of all peripheral focal adhesions, regardless 
of focal adhesion marker, showed no difference in focal adhesion number or area 




Materials and Methods: 
 
Cell culture:  Vcl-null mouse embryo fibroblasts (MEFs), a kind gift from Eileen 
Adamson, have been previously described (Xu et al., 1998) and were maintained in 
phenol-free, high glucose DMEM (Gibco 31053) supplemented with 10% FBS (Hyclone) 
and 2 mM glutamine (Gibco 25030).  HEK293 cells were provided by Dr. Peter 
Devreotes at Johns Hopkins University and were maintained in high glucose  DMEM 
supplemented with 10% FBS (Hyclone).  Cells were cultured at 37°C and 5% CO2 on 
tissue culture plastic coated with 0.1% gelatin. For transfer onto other growth substrates, 
cells were enzymatically lifted from the culture dish using 0.04% trypsin (Gibco 15090). 
 
Cell transfection:   2 x 106 cells were combined with 100 μL of Ingenio Electroporation 
Solution (Mirus MIR 50117) and 15 μg of appropriate DNA.  Cells were electroporated 
using setting T-20 on an Amaxa electroporation machine.  Electroporated cells were 
transferred to RPMI with 10% FBS and incubated for 10 min at 37°C to aid membrane 
closure.  Transfected cells were then transferred to 4 mL of phenol-free, high glucose 
DMEM (Gibco 31053) supplemented with 10% FBS (Hyclone) and 2 mM glutamine 
(Gibco 25030) and allowed to recover for 48 hrs before use in experiments. 
 
YFP-paxillin lysate for cytoskeletal experiments:   HEK 293 cells were seeded on 0.1% 
gelatin-coated 100 mm dishes at 3 x 106 per plate; transfection was performed the next 
day with 3 μg of plasmid DNA using Lipofectamine/Plus reagent (Invitrogen).  HEK 293 
cells were lysed 2.5-5 days after transfection with Stretch Assay Buffer (SAB) (20 mM 
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HEPES, 150 mM NaCl, 4 mM MgCl2, 0.05 mM CaCl2, 0.5 mM ATP, 1 mM PMSF, 1 
mM DTT, 0.02% BSA).  SAB+ refers to SAB with 2x protease inhibitor cocktail I (PIC 
I) and protease inhibitor cocktail II (PIC II)) from 1000x stocks .  1000x PIC I stock 
contained 1 mg/mL leupeptin, 2 mg/mL antipain, 10 mg/mL benzamidine, 10 KIU/mL 
aprotinin in H2O.  1000x PIC II contained 1 mg/mL chymostatin, and 1 mg/mL pepstatin 
in dimethyl sulfoxide.  Lysates were evaluated for fluorescence using a fluorimeter and a 
standard curve for EGFP/YFP concentration.   
 
Construction of the uniaxial stretch device:  The device is made from 6-gauge aluminum 
(base plate), stainless steel screws, and Teflon (slider bars and stabilizing plate), all of 
which are durable, easily cut, and inexpensive.  The base plate and slider bars are 
threaded, which allows the thumbscrews to stabilize the entire setup securely.  The device 
is resistant to ethanol and isopropanol, allowing it to be sterilized for use in cell-culture 
applications.  Coating of the aluminum base plate with a standard, matte, water-based 
paint was necessary to prevent corrosion in live-cell, incubated conditions.  Milling was 
use to cut exactly vertical lines in which the sliding screws could move, ensuring that 
each silicone chamber was stretched in exactly the same manner as the one next to it.  
The dimensions of the base plate and the spacing of the slider bar and secured screws 
were chosen to be compatible with a silicone chamber system already in use. The entire 
device was manufactured using a standard workbench drill and (for the larger device) 
lathe.  The cost of a single, reusable device, excluding the silicone chambers, can be 
approximated at <$100, the bulk of which is manual labor costs.   In order to modify the 
device for live cell imaging, the base plate was manufactured on a smaller scale to be 
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compatible with a Tokai Hit INUBTFP-WSKM-F1 onstage incubator mounted on a 
Nikon Eclipse Ti with a motorized stage. 
 
Cytoskeletal stretch assay:  Silicone stretch chambers (B-Bridge) were coated with 
human plasma fibronectin at 20 μg/ml (Gibco 33016) diluted in Dulbecco's Phosphate-
Buffered Saline (DPBS) and plated with 0.25x106 Vcl-null cells in DMEM supplemented 
with 10% FBS (Hyclone), 2 mM glutamine (Gibco 25030), penicillin (μg/mL), and 
gentamycin (20 μg/mL)   After 2 days (~80% confluency), the cells were rinsed twice 
with warm DPBS (37°C) and crosslinked to the fibronectin substrate using the cell 
impermeable reversible crosslinker 3,3´-Dithiobis(sulfosuccinimidylpropionate) (Sigma) 
at 1 mM in DPBS for 15 min at 37°C.  The cells were rinsed 2x and the crosslinking 
reaction quenched with 50 mM Tris-HCl pH 7.5 in DPBS for 15 min at 37°C.  The cells 
were then rinsed 2x with Stretch Assay Buffer (SAB) (20 mM HEPES, 150 mM NaCl, 4 
mM MgCl2, 0.05 mM CaCl2, 0.5 mM ATP, 1 mM PMSF, 1 mM DTT, 0.02% BSA) 
before being incubated with 0.003% digitonin in SAB+ to create digitonin-insoluble 
cytoskeletons.  The resulting cytoskeletons were rinsed once with SAB+ and stretched 
15% uniaxially on a Strex mechanical strain instrument (B-Bridge).  Exogenous proteins 
diluted in SAB+ were immediately added and the system was stretched for 5 min at 
37°C.  Stretched cytoskeletons were then rinsed with SAB+ before adding 100 μL 0.1% 
Triton X-100 diluted in SAB+.  Samples were scraped from the silicone substrate using 
the rounded edge of a pipette tip and stored at 0°C.   Live images of cell stretch were 
taken using the custom-built stretch device engineered to be compatible with a TokaiHit 




Immunoblotting:  Western blots were developed with species-specific infrared secondary 
antibodies  (Li-Cor) per the manufacturer's instructions.  YFP-labelled paxillin was 
detected with a lab developed, affinity-purified primary antibody EGFP-A (1:1300).   
G-11 anti-vinculin was obtained from Sigma and used at a 1:250 dilution.  Anti-actin C4 
(1:4000) was a kind gift from Dr. Jim Lessard.   
 
Microscopy of immunostained cytoskeletons:  Vcl-null cells were plated onto either poly-
L-lysine treated coverslips coated with 20 μg/mL human plasma fibronectin or 
fibronectin-coated stretch chambers and allowed to reach ~80% confluency.  
Cytoskeletons were created as above and fixed using 4% paraformaldyhyde in ddH20  
pH 7.3 at room temperature for 30 min and blocked using 2% goat serum.  Rabbit anti-
EGFP affinity purified antibody (EGFP-A) was made in lab and used at 1:1300 dilution , 
anti-talin 8D4 was used 1:50 (Sigma T3287) or used neat from a monoclonal supernatant.  
Coverslips were mounted in Prolong Gold Anti-Fade solution with DAPI. Confocal 
images were acquired on an upright LSM 510 (Carl Zeiss, Germany) microscope using 
Zeiss AIM software. Digital images were imported into Adobe Photoshop for figure 
preparation.  All other images were acquired on a Nikon Eclipse Ti using Elements 
software.    
 
Live imaging:  Transfected cells were plated on a silicone chamber (Strex ST-CH-10) 
coated with 20 μg/mL human plasma fibronectin (Gibco), and incubated at 37°C and 5% 
CO2 to recover for 48 hrs.  For experiments, chambers were mounted onto a manual 
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stretch device fitted to a Tokai Hit INUBTFP-WSKM-F1on-stage incubator mounted to a 
Nikon Ti Eclipse Microscope.  In order to stabilize the relatively thin bottom of the 
silicone chamber, a 22x50 mm No.1 cover glass was placed beneath the chamber in the 
unstretched state and removed for visualization during stretches.  Images were taken with 
a 40x CFI Plan Fluor ELWD NA 0.6 ELWD objective and a Photometrics HQ2 Coolsnap 
camera.   
 
Image Analysis:  All images were segmented and quantified using Nikon Elements 
software.  Fluorescent images collected using a 40x extra long working distance phase 
objective were first segmented to minimize cytoplasmic signal while preserving signal 
from focal adhesions using the Image Detect Peaks tool.  The resulting secondary images 
were inverted and then thresholded to create a binary that reflected only cellular focal 
adhesions.  This binary was then analyzed in Elements to report every focal adhesion as 
an object, without additional conversion of each object into a smooth ellipse.  Focal 
adhesion length is reported as the longest axis of each object.  Circularity is reported as 
the ratio of the length and width axes (a perfect circle = 1) using the formula Circularity = 
4* π *Area/Perimeter2 to include non-elliptical objects.  The perimeter is reported as the 
length of the outside boundary of an object and calculated using Elements’ application of 
Crofton’s formula where for a given object, the total perimeter = n *(Pr0 +Pr45 +Pr90 
+Pr135 )/4 using n as a given curve and Pr as a defined projection through space.  The 
focal adhesion angle was taken from the Elements output of Orientation, calculated by 
determining the angle between the long axis of an object and the horizon (set to be 
parallel with the direction of stretch).  Negative angles of orientation were avoided by 
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limiting all focal adhesions to occurring between 0 and 179 degrees from the horizon, 
with orientations greater than 90 degrees indicating that the focal adhesion extended in a 
direction opposite that of stretch.  A focal adhesion was categorized as perpendicular to 
stretch if the orientation was between 45 and 135 degrees.  All other orientations were 
considered parallel to the direction of stretch. 
 
Statistics:  All statistics were performed using Prism 5 by GraphPad software.  The 




This project began with a need to simultaneously apply external force and image living 
cells in order to detect focal adhesion change over time.  Previous labs have published 
their assays, but after much deliberation I chose to avoid the potential technical pitfalls of 
trying to recreate the highly specialized assays of other labs using our available 
equipment.   Investigation into more widely available methods for applying external force 
to cells  introduced me to two commercial systems designed to study the effect of 
externally generated tension on adherent cells or cytoskeletons, Flexcell and B-Bridge 
Strex.  These systems apply biaxial (Flexcell) or uniaxial (Strex) stretch to silicone-
based cell culture chambers and the tension generated on the chamber is transmitted to 
adherent cells.  While these commercial systems are available for purchase, I needed a 
device that was affordable and easily accessible to my lab.  I considered an ideal device 
one that would cost a fraction of what the commercial systems cost and yet be compatible 
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with commercially available, silicone-based cell-culture chambers.  To this end, I chose 
to purchase silicone-based cell culture chambers, but design my own device to generate 
tension on the chamber.   
 
After examination of how a Strex machine applies uniaxial stretch to a chamber, I 
realized I could construct a similar, manually operated device that depended on a sliding 
bar system secured with thumbscrews rather than automated pistons.  This manual device 
is constructed with a 6-gauge aluminum base plate for tensile strength, resistance to 
corrosion, and the ability to withstand autoclave conditions if necessary.  All other parts 
were constructed out of stainless steel to prevent corrosion in a humidified incubator.   
 
Operation of the device is simple.  The base plate has two sides.  One side has secured 
screws and the other has pre-drilled grooves that allow the center-to-center movement of 
the sliding screws to be exactly 5 mm.  Each silicone-based cell culture chamber sold by 
B-Bridge has a cell culture area of 3.2 mm x 3.2 mm and comes prefabricated with four 
holes for mounting onto the Strex machine.  On my device, one side of the chamber is 
immobilized by the secured screws on the baseplate.  The other side is sandwiched 
between the slider bar and the stabilization plate.  The sliding screws move the sliding bar 
from the unstretched position to the stretched position by traveling the complete distance 
of the grooves in the base plate.  This causes the sandwiched end of the chamber to move 
uniaxially 5 mm (Figure 3-1a).  This basic design was later turned into two different 
manual stretch devices.  One is designed to hold five chambers and is intended for use in 
in vitro cytoskeletal experiments (Figure 3-1b).  The other is designed on a smaller scale 
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and is only capable of holding one chamber, but the smaller device is compatible with the 
dimensions of a Tokai onstage incubator (Figures 3-1c and 3-1d).  On the smaller device, 
the slider bar is constructed out of Teflon to ease smooth transition from the unstretched 






















Figure 3-1:  Design of two simple, manually operated devices to study the effect of uniaxial 
stretch on cytoskeletons and live cells.  A.  Basic mechanism of both devices.  A silicone 
chamber is immobilized at one end while a sliding pull bar is moved to achieve the desired 
uniaxial stretch.  Thumbscrews are used to anchor the stretch for the desired amount of time.  B.  
The large device designed to stretch multiple chambers at once.  C.  The small-scale device, 
designed using the same principles, allows live imaging of stretched cells.  D. Small-scale device 







To characterize the device, I first measured the change in length experienced by the 
mounted chamber.  In my design, the moving end of the chamber is displaced 5 mm, 
theoretically increasing the length of the chamber from 3.2 cm to 3.7 cm, which provides 
a 15.6% uniaxial stretch.  To determine the actual stretch experienced by the chamber, I 
marked 1 cm vertical lines onto the cell culture area of the chamber with a marker and 
moved the sliding bar 5 mm.  To illustrate this displacement, a ruler was mounted 
underneath the chamber (Figure 3-2).  Using a camera mounted at a fixed distance above 
the chamber, the chamber was photographed in the unstretched and stretched positions.  
The resulting images were imported into Nikon elements and calibrated using the known 
dimensions of the chamber.  The length of the cell culture chamber is 3.23 cm in the 
unstretched state and 3.69 cm in the stretched state, resulting in a 14.2% stretch across the 
chamber (Figure 3-2).   Attempts to analyze the drawn lines using Elements software 
augmented manual error because the lines appeared as streaks or dots at high 
magnification.  Instead, to analyze the change in length of the lines drawn on the 
chamber, I printed large-scale versions of the unstretched and stretched chamber images 
and measured the line change manually using a ruler.  This approach showed that lines 









Figure 3-2:  Quantitation of the length change imposed on a silicone chamber using the 
manual device. Purchased, silicone-based cell culture chambers were marked with 5 mm black 
marker lines and mounted onto the large manual stretch device.  Using a camera mounted at a 
fixed distance above the chamber, the chamber was imaged in the unstretched position.  Then 
the slider bar was moved 5 mm to the stretched position and the chamber was imaged again.   
The resulting images were imported into Nikon elements and calibrated using the known 
dimensions of the chamber.  The total length of the chamber increases from 3.23 cm in the 
unstretched state to 3.69 cm in the stretched state, a 14.2% change.  Manual measurement of 




To demonstrate that tension generated using the manual device was transmitted to cells, I 
modified a published protocol (Sawada and Sheetz, 2002) to create Triton-insoluble 
cytoskeletons in order to create Vcl-null cytoskeletons.  Key modifications in the 
published protocol included 1) the addition of a reversible, cell-impermeable crosslinker 
(DTSSP) to bind the cells to the fibronectin-coated substrate and 2) using digitonin as 
opposed to Triton as the permeabilization agent (Figure 3-4).   
 
I then mounted a chamber with crosslinked cytoskeletons on the small-scale manual 
device.  Images were taken of cytoskeletons in the unstretched, stretched and released 
positions.  Quantification of 20 cytoskeletons in the various mechanical states showed 
that adherent cytoskeletons on average experienced a 13.8 ± 1.2% uniaxial stretch (Figure 
3-3).  When released from stretch, cytoskeletons returned to within 0.32% of their 
original length.  The data collected using adherent cytoskeletons stretched with the small 
device is in agreement with the data collected on the total stretch experienced by the 
silicone chamber (Figure 3-2), and indicates that the tension generated on silicone 












Figure 3-3:  Manual device applies stretch to cytoskeletons.  Vcl-null MEFs were crosslinked 
to a fibronectin-coated silicone-based cell culture chamber, permeabilized with 0.003% digitonin, 
washed, and fixed again with 0.4% PFA.  The resulting cytoskeletons were imaged in the 
unstretched, stretched, and released positions.  The resulting images were analyzed for uniaxial 
length changes in the direction of applied stretch.  A) Vcl-null cytoskeleton in three different 
mechanical states applied by the manual device.  Red bars = 10 μm.  B) 20 cells were analyzed 
for percent stretch applied by the manual device.  Average cell stretch was 13.8 ± 1.2%.  With 









To show that my manual device was comparable to commercially available devices, I 
chose to reproduce a published assay showing stretch-dependent binding of cytosolic 
proteins to Triton-insoluble cytoskeletons (Sawada and Sheetz, 2002).  To do this, I 
modified the published protocol to be compatible with digitonin-insoluble Vcl-null 
cytoskeletons prepared from live cells crosslinked to fibronectin-coated substrate with a 





















Figure 3-4:  Protocol for stretch-dependent binding of exogenous proteins to digitonin-
insoluble cytoskeletons.  Vcl-null cells were cultured on a fibronectin-coated silicone substrate 
and allowed to grow for 48 hrs to reach 80-90% confluency.  After washing with DPBS, the cells 
were crosslinked to the fibronectin substrate using the reversible, cell impermeable crosslinker 
DTSSP.  Crosslinked cells were then washed into the stretch assay buffer (SAB) and digitonin-
insoluble cytoskeletons were created by treatment with 0.003% digitonin at RT for 2 min in SAB 
with protease inhibitors (SAB+).  To probe for stretch-dependent binding of exogenous proteins, 
cytoskeletons were stretched 15% uniaxially before adding exogenous proteins diluted in SAB+.  
The cytoskeletons were stretched for 5 min at 37°C.  After washing, stretched cytoskeletons and 
bound proteins were collected by scraping the samples from the silicone substrate using 0.1% 
























As a control, I tested the binding of exogenous paxillin  from cell lysates to Vcl-null 
cytoskeletons.  Paxillin has been previously shown to bind in a stretch-dependent manner 
to Triton-insoluble cytoskeletons (Sawada and Sheetz, 2002).  Additionally, I decided to 
test the binding of bacterially expressed and purified vinculin domain 1 (VD1) to 
stretched cytoskeletons.  VD1 interacts with talin (Price et al., 1989) and is sufficient to 
co-immunoprecipitate with talin in vitro (Gilmore et al., 1992).  Furthermore, it has been 
shown that mechanical stretch applied directly to a portion of talin rod unmasks cryptic 
vinculin binding sites and increases the binding of VD1 to talin (del Rio et al., 2009).  
From this data, I hypothesized VD1 would show stretch-dependent binding to 
cytoskeletons because uniaxial stretch would uncover cryptic binding sites in cytoskeletal 
talin for VD1.   
 
My experiments using digitonin-insoluble cytoskeletons began by looking at the stretch-
dependent binding of paxillin and VD1 on the Strex Machine.  Using the commercial 
device, I was able to reproduce the previously published result that paxillin has stretch-
dependent binding to cytoskeletons.  Furthermore, VD1 also showed stretch-dependent 
binding to cytoskeletons.  The results became the basis for another project, which will be 
discussed in detail in Chapter 4.  Because this preliminary data encouraged me to pursue 
further data on the interaction of VD1 with the cytoskeleton, I chose VD1 as the 
exogenous protein with which to compare my manual device to the Strex machine.   
Using VD1 as a model for binding of exogenous proteins to cytoskeletons, my data 
showed that the performance of the Strex machine and my manual device was nearly 
identical (Figure 3-5a).  More recently, I attempted to show that there is similar 
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performance between the manual device and the Strex machine using paxillin as the 
model protein.  Unfortunately, I have only collected positive data for that once (Figure 3-























Figure 3-5:  Commercial and manual devices are comparable for detecting the stretch-
dependent binding of exogenous proteins by Western blot.  Digitonin-insoluble Vcl-null 
cytoskeletons were created as previously described.  One mL of 1-μM recombinant VD1 in SAB+ 
or 100-nM YFP-paxillin in HEK lysate diluted in SAB+ were incubated with either unstretched or 
stretched cytoskeletons for 5 min at 37°C.  After washes, cytoskeletons with bound protein were 
scraped from the FN-coated silicone substrate, resolved on a 4-12% acrylamide gel, and 
transferred to nitrocellulose for Western blotting.  Western blots were scanned and quantified 
using a Licor infrared imaging system.  All data was normalized to an actin loading control.  U = 
unstretched, S = stretched.  A) Comparison of stretch-dependent binding on the Strex machine 
versus manual device using 1-μM recombinant VD1 purified from bacteria.  B) Comparison of 
stretch-dependent binding on the Strex machine versus manual device using 100-nM YFP-paxillin 
in HEK lysate.  There is near identical performance between the commercial and manual devices.  
Bars indicate S.E.M, n = 3. 





These characterization steps (Figures 3-2, 3-3, and 3-5) were considered evidence that the 
manual device was able to apply uniaxial stretch to an adherent cell in a manner 
comparable to a commercial Strex device.  I then began testing the smaller device 
designed to fit into a Tokai onstage incubator for feasibility of use during live cell 
imaging.  Ideally, my system would allow real-time microscopy of live cells in the 
unstretched, stretched, and released state.  This system would allow me to use Vcl-null 
cells transfected with mutants of vinculin to pursue information about the role of 
vinculin, its autoinhibition, and its ligand binding abilities on focal adhesion growth in 
response to external force.  Testing of the device highlighted several design limitations 
when used in conjunction with live microscopy.  First, stretching the chamber uniaxially 
changes the focal plane (z-plane) and viewing field (x, y coordinates) during stretch.  I 
accommodated these changes by noting the coordinates of fiduciary landmarks 
introduced to the culture chamber (usually an intentionally introduced orienting scratch 
wound) and characterizing the typical xyz shift of the chambers with stretch (data not 
shown).  Secondly, imaging of live cells required the use of an extra-long working 
distance (ELWD) phase objective due to both the light dispersing properties of silicone 
and the shifting z-plane of the chamber.  When the device was developed, I had access to 
a 40x ELWD objective, so that is the magnification at which I conducted my live cell 
experiments.     
   
Vcl-null mouse embryonic fibroblast (MEF) cells were transfected with YFP-paxillin, 
eGFP-vinculin, eGFP-Vh, or eGFP-T12.  For each construct, timelapse control cells were 
imaged at 0 min, 5 min, and 10 min.  To analyze the effect of stretch, cells were imaged 
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immediately before stretching (U), after 5 min of 13.8% uniaxial stretch (S), and after 
having been released from stretch for 5 min (R).   The timelapse control and stretched 
cell data sets were unpaired.  The collected images were converted into quantifiable 
binaries of the peripheral focal adhesions of cells (Figure 3-6).  Visual inspection of some 
initial image sequences indicated that YFP-paxillin-expressing Vcl-null cells show 
increased focal adhesion number or size with stretch (Figure 3-7) as has been previously 
published (Sawada 2002).  Indeed, across several experiments, individual cells showed 


















Figure 3-6:  Manual stretch device allows the quantification of focal adhesion changes with 
time or mechanical stretch.  Vcl-null mouse embryonic fibroblasts (MEF) cells were transfected 
with eGFP-tagged constructs and allowed to recover for 48 hrs before experimentation. Cells 
were imaged with a 40x ELWD phase objective. The images were then segmented and converted 
into binaries reflecting the dimensions of peripheral adhesions and quantified using Nikon NIS-
Elements. Red bars = 5 μm.  A) YFP-paxillin transfected Vcl-null MEF in the unstretched, 
stretched, and released mechanical state.  B) eGFP-vinculin transfected Vcl-null MEF in the 






Figure 3-7:  Visual inspection of images of stretched cells encourage the conclusion that 
acute uniaxial stretch causes focal adhesion growth.  Vcl-null cells transfected with  
YFP-paxillin as a marker of focal adhesions were imaged with 40x ELWD phase objects in their 
unstretched, stretched, and released states.  Red bar = 5 μm.   Cell 1 shows a typical timelapse 
image set indicating that focal adhesion number increases with stretch.  Cell 2 shows a typical 
timelapse image set indicating that some focal adhesions may increase in size with stretch and 











To determine if there was a significant, stretch-dependent change, I analyzed the 
peripheral focal adhesions of 5 randomly chosen timelapse control cells and 5 stretched 
cells.  Peripheral focal adhesions were examined because the vast majority of transfected 
cells contained peripheral focal adhesions in their protrusions, while relatively few had 
any central adhesions.  All images were segmented, and the areas of peripheral focal 
adhesions were quantified using Nikon Elements software.  Several transformations were 
attempted on the data before determining that the square root transformation results in a 
sufficiently normal distribution of data points to enable comparison of the data groups by 
methods such as ANOVA that require approximately normal data distributions.   
 
Additionally, while all YPF-paxillin-expressing cells showed some evidence of focal 
adhesion change with stretch, I focused our initial analysis on the 5 stretched cells that 
showed the greatest response.  This was done in hopes of capturing any trends in focal 
adhesion change that may be present.  The timelapse cells appeared to have a consistent 
amount of focal adhesion change across all cells imaged, and so 5 timelapse control cells 
were chosen at random. 
 
Quantification of all peripheral focal adhesions in YFP-paxillin-expressing Vcl-null cells 
showed only one cell (Cell 5) with significant stretch-dependent changes in peripheral 
focal adhesion area and length (Figure 3-8a), despite visual inspection of the data having 
suggested focal adhesion change in all five stretched cells.  A comparison of the number 
of focal adhesions at each timepoint in the experiment between timelapse control and 
stretched cells showed 2 out of 5 cells (Cells 4 and 5) having significantly increased 
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numbers of focal adhesions (Figure 3-8b).  While limited by sample size, this data 
remained encouraging because the only cells showing significant change in focal 
























Figure 3-8:  There was no difference in FA area, length, or number over time, with or 
without a stretch and release protocol, in YFP-paxillin-expressing Vcl-null cells.  A) Cells 
imaged at 0 min, 5 min, and 10 min were used as timelapse controls compared to cells imaged in 
the unstretched (U), stretched (S), and released (R) states. Live images were converted into 
binaries of peripheral focal adhesions and analyzed for changes in focal adhesion area and 
length.   A square root transformation was applied to the resulting data to allow analysis by 
ANOVA.  * implies p<0.01, ** implies p<0.001. B)  Total number of focal adhesions at each 
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Although both paxillin and vinculin are focal adhesion proteins and accepted focal 
adhesion markers, I hypothesized that different focal adhesion proteins may respond 
differently to uniaxial stretch.  It was possible that eGFP-vinculin containing focal 
adhesions would respond differently to uniaxial stretch.  Therefore, I decided to analyze 
similar images collected for eGFP-vinculin.  Additionally, I hypothesized that Vcl-null 
cells expressing a truncation mutant of vinculin previously shown to increase focal 
adhesion number (Xu et al., 1998) and increase cell adhesion strength (Dumbauld, 2013) 
would  respond differently to uniaxial stretch compared to Vcl-null cells expressing full-
length vinculin.  I also expressed eGFP-T12 in Vcl-null cells to determine whether an 
autoinhibition mutant of vinculin would affect the focal adhesion response to external 
force.  However, these images were not analyzed because these cells showed a propensity 
for detaching from the substrate after release from stretch.  The images of eGFP-vinculin 
and eGFP-Vh transfected cells showed no change in focal adhesion area, length, or 
number that occurred in greater frequency in stretched cells than in timelapse control 













Figure 3-9:  There was no difference in FA area, length, or number over time, with or 
without a stretch and release protocol, in EGFP-vinculin-expressing Vcl-null cells.  
A) Cells imaged at 0 min, 5 min, and 10 min were used as timelapse controls compared to cells 
imaged in the unstretched (U), stretched (S), and released (R) states. Live images were 
converted into binaries of peripheral focal adhesions and analyzed for changes in focal adhesion 
area and length.   A square root transformation was applied to the resulting data to allow analysis 
by ANOVA.  * implies p<0.01, ** implies p<0.001. B)  Total number of focal adhesions at each 










Square Root Transformation of 
 Focal Adhesion Area (μm) 
Square Root Transformation of 
 Focal Adhesion Area (μm1/2) 
Name of Cell Analyzed Name of Cell Analyzed 























































Figure 3-10:  There was no difference in FA area, length, or number over time, with or 
without a stretch and release protocol, in EGFP-Vh-expressing Vcl-null cells.  A) Cells 
imaged at 0 min, 5 min, and 10 min were used as timelapse controls compared to cells imaged in 
the unstretched (U), stretched (S), and released (R) states. Live images were converted into 
binaries of peripheral focal adhesions and analyzed for changes in focal adhesion area and 
length.   A square root transformation was applied to the resulting data to allow analysis by 
ANOVA.  * implies p<0.01, ** implies p<0.001. B) Total number of focal adhesions at each 
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I hypothesized that focal adhesion change may be dependent on the angle between the 
focal adhesion and the direction of uniaxial stretch, with perhaps only focal adhesions 
oriented in a particular way to the direction of external force being able to undergo a 
reinforcement response.  To analyze this, the focal adhesions for eGFP-vinculin 
transfected Vcl-null cells were segregated according to whether they were parallel or 
perpendicular to the direction of stretch.  Segregating the data according to the angle of 
the focal adhesion yielded no trends with regard to parallel versus perpendicular focal 
adhesions (Figure 3-11), and those cells that showed significance were the same ones that 
showed significance when all peripheral focal adhesions were pooled (Figure 3-11 
compared to Figure 3-9a).  In one instance (Cell 3), the segregation of focal adhesions by 















Figure 3-11:  The angle of a focal adhesion relative to the direction of stretch has no effect 
on focal adhesion length.  The peripheral focal adhesions from 5 stretched EGFP-vinculin-
expressing Vcl-null cells were further analyzed.  Focal adhesions were categorized as parallel to 
the direction of stretch or perpendicular to the direction of stretch.  A square root transformation 
was applied to the resulting data to allow analysis by ANOVA.  Only cells that showed significant 
length changes in the pooled data showed significant changes when the data was categorized by 
angle.  Significant change did not correlate with the focal adhesion being parallel or perpendicular 






















The lack of significant trends in focal adhesion area or length with stretch led me to 
investigate whether the cells were responding with another type of global change.  For 
instance, perhaps the cells were changing the total surface area of the cell immobilized to 
the substrate instead of changing the size of individual focal adhesions.  To determine if 
any such trends were present, eGFP-vinculin transfected cells were analyzed individually 
for changes in total cell area, perimeter, and circularity with time.  To do this, the values 
of each metric were plotted with time (Figure 3-12) both linear and nonlinear regressions 
were performed on each plot to yield a slope quantifying the degree of change 
experienced.  The slope values for timelapse control cells (n=4) versus stretched cells 
(n=5) were not significantly different using any metric. Therefore, while individual cells 
could show impressive changes in area, perimeter, or circularity with stretch, there were 














Figure 3-12: Timelapse control cells show no increased change in morphology over 
stretched cells.  Timelapse control cells (n=4) and stretched cells (n=5) were analyzed for 
changes in total cell area, perimeter, and circularity.  While individual stretched cells may have 
shown significant changes in any one of these parameters, there is no correlation between the 





























The lack of focal adhesion response with the application of uniaxial stretch was, at first, 
very puzzling.  I had characterized my device and shown that not only was it capable of 
applying stretch to silicone-based cell culture chambers, but that the stretch generated 
was transmitted to cytoskeletons adherent to the silicone.  Previous to my work, the 
literature showed a correlation between focal adhesion size and traction force, and several 
more recent studies had shown that the application of external force was correlated with 
increased focal adhesion size.  It remained unclear to me what aspects of my assay could 
have led to the application of external force having no effect on focal adhesions.   
 
Upon consideration of the conditions of my assay, I realized that all of my observations 
were on adherent spread cells that had been plated at least 48 hrs to allow the cells to 
recover from electroporation.  Furthermore, due to the technical limitations of my setup, I 
was imaging focal adhesions at 40x.  This information indicated that I had been 
observing the effects of external force on established, likely mature, focal adhesions and 
may have missed the responses of smaller, immature focal adhesions.  Knowing this, I 
began to question what was currently known about the responses of nascent focal 
adhesions versus established, mature focal adhesions to external force.   
 
I reviewed previous studies on the effects of external force on focal adhesion size to look 
for indications as to what populations of focal adhesions had been studied.  Surprisingly, 
no single study has explored the effect of external force on different subpopulations of 
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focal adhesions using the same assay.  However, there are published results showing that 
application of external force causes increased focal adhesion size may have been 
conducted using assays that weighed the observations towards the responses of nascent 
focal adhesions.  For example, in Riveline’s seminal study, his methods section indicates 
that all of his experiments were conducted in serum-free media.  It is unclear from the 
paper why serum-free conditions were necessary, but it has been established that serum-
free cell culture conditions limit focal adhesion maturation due to a lack of 
lysophosphatidic acid, a growth factor that activates rho-dependent focal adhesion 
maturation (Ridley and Hall, 1992; Choi et al., 2008).  This indicates that Riveline’s 
observations of the response of focal adhesions to external force may have actually been 
limited to the responses of nascent focal adhesions to external force.  It also suggests why 
he saw stretch-dependent changes in focal adhesions in 18 out of 18 cells tested (Riveline 
et al., 2001).   
 
Similarly, Galbraith showed that external force results in focal adhesion growth 
(Galbraith et al., 2002).  However, the conditions of her assay depend on the formation of 
nascent focal adhesions on the dorsum of a cell.  In her assay, 1 μm, fibronectin-coated 
beads are placed at the lamellipodia of fibroblasts to establish an initial ECM-membrane 
contact.  In the absence of external force, this bead then moves toward the center of the 
cell as the cell membrane continues to protrude and migration continues.  To exert 
external force, Galbraith used an optical trap to prevent the cell from using these initial 
contacts to move the beads in a retrograde fashion.  In her assay, she saw that in response 
to this external force, the ECM-membrane contacts recruited vinculin and increased in 
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size.  Again, here is a study well accepted to show a link between the application of 
external force and focal adhesion size that likely was observing the responses of nascent 
focal adhesions.   In Galbraith’s assay, the responses of established, ventral focal 
adhesions were not measured.     
 
While no single study has looked at the effects of nascent versus mature focal adhesions 
using a single assay, there are two pieces of data in the literature that indicate that the two 
subpopulations of focal adhesions may respond differently to external force.  Sniadecki 
monitored the focal adhesion response of spread, adherent fibroblasts plated onto 
magnetically controlled microposts (Sniadecki et al., 2007).  In his assay, he found that a 
single actuation of a magnetic post was not sufficient external force to cause significant 
changes in focal adhesion size.  Rather, multiple actuations of the magnetic posts applied 
over a ten min period were necessary to cause significant changes in focal adhesion size.  
Additionally, his data does not indicate whether the degree of focal adhesion growth 
reported (an average 2-fold growth in focal adhesion area) was a global response or 
occurred only in a subset of focal adhesions.   
 
Finally, Stricker measured the traction forces generated by the established focal 
adhesions of spread cells when their polyacrylamide growth substrate was stretched 
(Stricker et al., 2011).  In his results, he presents the data for two established focal 
adhesions that show that established focal adhesions are capable of generating large 




In this study I present an assay to introduce external stress to a cell by stretching the 
extracellular substrate, an approach similar in many ways to both Sawada (Sawada and 
Sheetz, 2002) and Stricker’s (Stricker et al., 2011) work.  I verified that the device 
delivers stretch to the silicone-based cell culture chamber (Figure 3-2), and that this 
stretch is transmitted to adherent cytoskeletons (Figure 3-3).  Adherent cytoskeletons 
experienced a 13.8 ± 1.3% uniaxial stretch.  Furthermore, I showed that, when using 
Western blotting to quantify the binding of an exogenous protein, my device performed 
similarly to a commercially available machine designed to apply stretch to cells.  A 
small-scale model of this device was designed to function on a microscope stage during 
live cell imaging, allowing  data to be collected on the response of focal adhesions 
containing eGFP-tagged proteins before, during, and after the application of uniaxial 
stretch.   
 
Of course, there are caveats to the use of this device, especially as applies to live 
imaging.  First, the need to manually introduce stretch limits the time resolution of 
timelapse studies.  This is due to 1) the time needed to secure the screws maintaining 
stretch and 2) the resulting change in z-plane that is introduced when the chamber itself is 
stretched.  In my experience, I found that the most consistent timepoints could be 
collected when they were spaced at least five min apart.  If changes in a protein or 
structure of interest occur more quickly than this, any changes due to stretch will not be 
observed using this device.  However, previous studies have used similarly spaced 
timepoints (Riveline et al., 2001; Sawada and Sheetz, 2002), so I do not believe that the 
spacing of my timepoints was the reason I did not detect similar changes in focal 
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adhesion size and number.   
 
Second, the elasticity of the substrate comes at the cost of an optically clear substrate.  
The different refractive indexes of PDMS (the silicone basis of commercially available 
stretch chambers) versus German coverglass (1.4 vs 1.515) (MIT Material Properties 
Database) leads to greater dispersion of light when attempting to image samples on 
silicone substrates using an inverted microscope and prevents the use of TIRF and 
confocal microscopy that are accessible when using glass substrates.  I addressed this 
short-coming by conducting my studies using an available, lower magnification ELWD 
phase objective.  This allowed me image focal adhesions as they were being stretched, 
but limited the detail that I could observe. 
 
The technical limitation of changing xyz coordinates between timepoints imposed several 
limitations on the analysis of the collected data.  First, while many cells could be imaged, 
very few cells remained in focus throughout the entirety of the experiment.  Second, the 
changing z-planes inherent in these experiments make it impossible to compare focal 
adhesion intensity accurately.  Finally, the moving x-y coordinates meant that the images 
taken between the unstretched, stretched, and released states are not perfectly registered, 
making it impossible to definitively identify a single focal adhesion throughout the 
entirety of the experiment.  As a result, in our analysis of the collected data, we had to 
include all focal adhesions in each cell instead of tracking particularly interesting ones, 
such as nascent focal adhesions.  This limited our analysis to average focal adhesion size 
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and number in the unstretched, stretched, and released state rather than allowing 
timecourse information on the response of individual focal adhesions to external force.  
 
The collected data on visual inspection suggested that acute uniaxial stretch was causing 
focal adhesion growth and changes in focal adhesion number (Figure 3-7).  However, 
after quantitation it became obvious that neither the act of stretching the cell or releasing 
the cell from stretch had a discernible effect on average focal adhesion area or number 
(Figures 3-8, 3-9, and 3-10).  Furthermore, there was no significant difference in focal 
adhesion size or number when stretched cells were compared to unpaired, timelapse 
controls.  From this I can only conclude that visual analysis of focal adhesion change can 
be misleading unless the changes seen are easily calculated by eye and occur in the 
majority of focal adhesions present.  
 
My study focuses on the response of mature focal adhesions to acute, uniaxial stretch.  
Vcl-null cells were plated 48 hrs before study and allowed to grow to 80% confluency, 
allowing ample time for focal adhesion development and maturation.  In light of my 
results and what I now know about the subpopulations of focal adhesions likely observed 
in previous studies, I believe that I observed no significant changes in focal adhesions 
because my observations were on established, mature focal adhesions.  There are two 
publications that examine the effect of external stretch on mature focal adhesions in 
living cells.  Sawada’s data only presents the response of a single cell and lacks timelapse 
controls (Sawada and Sheetz, 2002).  Stricker’s data shows that external stretch causes 
increases in traction stress in focal adhesions, but does not always result in increased 
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focal adhesion size (Stricker et al., 2011).  My data shows that individual cells 
undergoing stretch may show significant focal adhesion responses, but there is no trend 
for established focal adhesions in stretched cells to show a greater change in focal 
adhesion size than the focal adhesions of control cells.    
 
I believe that, currently, studies on the effects of external force on focal adhesion growth 
do not take into account that focal adhesions mature along a continuum from nascent to 
mature focal adhesions.  It is possible that different subpopulations of focal adhesions 
respond differently to external force.  Furthermore, the role for vinculin in regulating the 
focal adhesion response to force may be different in these different subpopulations.  My 
study and analysis suggests that effects of external force on focal adhesions should be 
studied in a single system that allows the observation of focal adhesions along the 
maturation continuum from nascent adhesions, through focal complexes, and finally 
mature adhesions.  My assay could be modified to do this by 1) correcting the discussed 
shortcomings of the current method for applying stretch and 2) varying the conditions of 
the experiment to limit focal adhesion maturation.   
 
Suggested mechanical revisions to the device include incorporation of two sliding bars 
rather than one (Figure 3-1) in order to minimize xyz shift of the viewing field and 
thereby increase the time resolution of timelapse studies.  Additionally, the introduction 
of pressure clamps to secure any sliding bars (as opposed to thumbscrews) would allow 
for imaging of samples sooner after the introduction of stretch.  Both of these 
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modifications could be made easily and inexpensively, expanding the potential uses of 
this manual device.   
 
The conditions of the assay could be modified to limit focal adhesion maturation by 
developing a system that uses short-term serum starvation of cells transfected with eGFP-
tagged focal adhesion markers.  An alternative approach would be to introduce inhibitors 
that affect key signaling proteins in focal adhesion maturation.  For example, 
microinjection of fibroblasts with the exoenzyme C3 transferase from Clostridium 
botulinum has been shown to inhibit rho-signaling (Ridley and Hall, 1992), a key 
activator of focal adhesion maturation.   Additionally, cells could be incubated with 
Y27632, a compound that inhibits Rho-Kinase (ROCK), a signaling protein downstream 
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Role of Vinculin Autoinhibition in the  
















A published study has shown that several focal adhesion proteins show stretch-dependent 
binding when added exogenously to Triton-insoluble cytoskeletons.  However, in that 
study, full-length vinculin did not respond in a similar manner.  Since vinculin is 
autoinhibited, I hypothesized that if vinculin were activated before being exposed to 
stretched cytoskeletons, it would also be able to bind in a stretch-dependent manner.  A 
previously published study has also shown a portion of talin rod can be mechanically 
stretched to uncover cryptic binding sites for vinculin.  From this data, I hypothesized 
that perhaps mechanical stretch of the cytoskeleton was sufficient to uncover cryptic 
binding sites in talin rod for vinculin and increase the recruitment of vinculin to focal 
adhesions.  To determine the effect of activation on vinculin’s ability to bind 
cytoskeletons in a stretch-dependent manner, I first developed a method for creating 
digitonin-insoluble Vcl-null cytoskeletons.  As a positive control, digitonin-insoluble 
cytoskeletons were also incubated with paxillin, which has been previously shown to 
bind in a stretch-dependent manner to cytoskeletons.  Initial experiments showed that 
exogenous paxillin bound to digitonin-insoluble cytoskeletons in a stretch-dependent 
manner, as previously reported. Then, digitonin-insoluble cytoskeletons were incubated 
with exogenous vinculin and various vinculin truncation mutants.  Full-length, 
autoinhibited vinculin did not bind cytoskeletons in a stretch-dependent manner, as 
previously reported.  However, domain 1 of vinculin (VD1), when expressed alone, 
showed stretch-dependent binding to digitonin-insoluble cytoskeletons.  Incubation of 
digitonin-insoluble cytoskeletons with VD1 containing a well characterized mutation that 
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ablates vinculin-talin and vinculin-alpha-actinin interactions reduced stretch-dependent 
binding.  This result indicated that the stretch-dependent binding of VD1 was due to 
interactions between VD1 and talin or alpha-actinin.  However, subsequent imaging 
studies showed that exogenous VD1 did not localize to focal adhesions in this assay.  
Instead, VD1 showed a generalized punctate binding pattern to cytoskeletons not 
consistent with any known localization of vinculin.   The stretch-dependent binding of 
VD1 was not reproduced using a truncation mutant of vinculin, vinculin head (Vh), 
which contains domains 1 through 4.  I interpret my results from this study as indicating 
that the method I developed for creating digitonin-insoluble cytoskeletons was sufficient 
for reproducing the result that paxillin binds in a stretch-dependent manner to 
cytoskeletons, but lacked a critical localization factor that would make this my assay an 
appropriate system to study how vinculin’s autoinhibition and direct stretch applied to the 















A key question in mechanotransduction is how the actomyosin cytoskeleton mediates 
both intracellular forces and external forces to affect cellular function and signaling.  
Through focal adhesions, there is a structural coupling between the extracellular matrix 
(ECM), integrins, and actin filaments.  This suggests that focal adhesions could play a 
key role as mechanosensors that respond to changes in intracellular or extracellular force.  
Several studies have demonstrated that there is a positive, linear correlation between 
focal adhesion size and the traction force a focal adhesion can exert on the extracellular 
matrix (Balaban et al., 2001; Tan et al., 2003; Goffin et al., 2006) for many, but not all, 
focal adhesions.  Furthermore, studies have shown that focal adhesions increase in size in 
response to external forces through the recruitment of additional focal adhesion proteins 
(Riveline et al., 2001; Galbraith et al., 2002; Sawada and Sheetz, 2002; Sniadecki et al., 
2007).  However, the mechanism of how these focal adhesion proteins are recruited 
remains unclear.   
 
Several studies have shown that direct application of force to purified domains of focal 
adhesion proteins exposes cryptic phosphorylation or ligand-binding sites.  When amino 
acids 115-420 of p130Cas are bound to a latex substrate and stretched, there is a positive, 
linear correlation between the extent to which the latex is stretched and the amount of 
p130Cas115-420 phosphorylation (Sawada et al., 2006).   Similarly, when amino acids 
482-889 of talin rod are mechanically stretched using magnetic tweezers, the binding of 
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vinculin head to talin482-889 increases with the amount of force applied to talin482-889 
(del Rio et al., 2009).   
 
Together, these two studies indicate that some focal adhesions proteins may be able 
respond to changes in cytoskeletal tension by altering their ligand binding abilities.  One 
could hypothesize that increased cytoskeletal tension results in increased ligand binding 
abilities in some focal adhesion proteins.  If so, this would be a potential mechanism by 
which focal adhesion proteins are recruited when external forces are applied to a cell.  
This hypothesis could be extended to propose that increased cytoskeletal tension may 
uncover cryptic binding sites on talin for vinculin, leading to increased talin:vinculin 
interactions.  If so, application of external force to a cell would result in increased 
talin:vinculin interaction, providing a potential mechanism for vinculin recruitment to 
focal adhesions when external force is applied to cells.    
 
An alternative hypothesis to explain these findings could be the application of catch bond 
theory (Kramers, 1940; Bell 1978; Dembo et al., 1988), and is supported by the several 
systems where it has been shown that intramolecular bond lifetimes can increase with 
force.  Catch bonds have been confirmed experimentally for other adhesion proteins 
including actin binding to myosin (Guo et al., 2006), fibronectin binding to integrin 
(Kong et al., 2009), and P-selectin/L-selectin binding to P-selectin glycoprotein ligand 1 
(Fritz et al., 1998; Evans et al., 2001; Marshall et al., 2003; Yago et al., 2004; Barsegov 
et al., 2005).  Using the catch bond theory, it has been proposed that the molecules 
involved undergo a structural conformation change that allows for firmer attachment 
 
 132 
(Lou et al., 2007, Yakovenko et al., 2008).  Likewise, one could hypothesize that 
increased cytoskeletal tension results in firmer attachment between vinculin and talin, 
allowing increased time for recruitment of additional focal adhesion proteins.  This could 
be an alternative potential mechanism for the recruitment of to focal adhesions when 
external force is applied to cells.    
 
Biaxial stretch of cytoskeletons has been used as a model to determine the stretch-
dependent binding of exogenous proteins to cytoskeletons.  These experiments found that 
paxillin and focal adhesion kinase (FAK) bind Triton-insoluble cytoskeletons in a stretch-
dependent manner (Sawada and Sheetz, 2002).  Both of these proteins are ligands for 
vinculin, are present in nascent focal adhesions, and remain present throughout focal 
adhesion maturation (Choi et al., 2008).  Interestingly, vinculin itself does not bind to 
Triton-insoluble cytoskeletons in a stretch-dependent manner (Sawada and Sheetz, 2002).  
Based on this data, I hypothesized that vinculin did not bind in a stretch-dependent 
manner because full-length vinculin is autoinhibited and unable to bind ligands.   If an 
activated form of vinculin were incubated with Triton-insoluble cytoskeletons, the 
application of stretch to those cytoskeletons would cause activated vinculin to also be 
bound in a stretch-dependent manner.  Furthermore, I hypothesized that the stretch-
dependent binding of activated vinculin would occur because stretch applied to 
cytoskeletons would be sufficient to uncover previously cryptic binding sites on 





In this study, I build on my previous work where I developed digitonin-insoluble 
cytoskeletons created from Vcl-null mouse embryonic fibroblasts (MEFs).  To determine 
whether my digitonin-insoluble cytoskeletons were appropriate for observing the stretch-
dependent binding of exogenous proteins, I incubated digitonin-insoluble cytoskeletons 
with paxillin and probed for stretch-dependent binding.  Using digitonin-insoluble 
cytoskeletons, I was able to reproduce the previously published result that paxillin binds 
in a stretch-dependent manner to cytoskeletons.  I then tested the hypothesis that 
vinculin’s ability to bind to a cytoskeleton is dependent on the accessibility of the talin-
binding site on vinculin head.  To do this, I incubated digitonin-insoluble Vcl-null 
cytoskeletons with full-length vinculin and mutants of vinculin lacking a tail domain (and 
therefore incapable of autoinhibition).   Additionally, I tested the hypothesis that 
stretching a cytoskeleton would be sufficient to uncover previously cryptic binding sites 
on talin for vinculin.  To do this, I incubated digitonin-insoluble Vcl-null cytoskeletons 
with mutants of vinculin containing an A50I point mutation that ablates binding of 
vinculin to talin and alpha-actinin (Bakolitsa et al., 2004).  
 
My results showed full-length vinculin shows no stretch-dependent binding to digitonin-
insoluble cytoskeletons.  This result is in agreement with previous studies (Sawada and 
Sheetz, 2002).  However, it was found that domain 1 of vinculin (AA1-258) binds to 
digitonin-insoluble cytoskeletons in a stretch-dependent manner.  This stretch-dependent 
binding is ablated when VD1 contains an A50I point mutation.  These results prompted 
me to conduct imaging studies to determine the localization of VD1 in digitonin-
insoluble cytoskeletons.  Confocal microscopy showed that VD1 bound to cytoskeletons 
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binds in a punctate pattern unlike any known localization of vinculin.  Furthermore, VD1 
bound to cytoskeletons does not localize to focal adhesions.  Attempts to recreate the 
stretch-dependent binding of VD1 using another truncation mutant of vinculin, vinculin 
head (Vh), did not reproduce the results found with VD1.  My results lead to me conclude 
that the stretch-dependent binding of VD1 may reflect a spurious binding ability of this 
30 kDa domain of vinculin and does not reflect a physiologic ability of activated vinculin 




Cell culture:  Vcl-null mouse embryo fibroblasts (MEFs), a kind gift from Eileen 
Adamson, have been previously described (Xu et al., 1998).  Cells were maintained using 
phenol-free, high glucose Dulbecco's Modified Eagle Medium (DMEM, Gibco 31053) 
supplemented with 10% FBS (Hyclone) and 2 mM glutamine (Gibco 25030).  HEK293 
cells were provided by Dr. Peter Devreotes at Johns Hopkins University and were 
maintained in DMEM supplemented with 10% FBS (Hyclone).  Cells were cultured at 
37°C and 5% CO2 on tissue culture plastic coated with 0.1% gelatin. For transfer onto 
other growth substrates, cells were enzymatically lifted from the culture dish using 0.04% 
trypsin (Gibco 15090). 
 
Protein Transfection and/or Isolation:   EGFP-Vinculin (1-1066), EGFP-VD1, EGFP-
VD1A50I, EGFP-Vh, EGFPVhA50I, and YFP-Paxillin:  HEK 293 cells were seeded on 
0.1% gelatin-coated 100 mm dishes at 3 x 106 per plate; transfection was performed the 
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next day with 3 μg of plasmid DNA using Lipofectamine/Plus reagent (Invitrogen).  HEK 
293 cells were lysed 2-5 days after transfection with Stretch Assay Buffer (SAB) (20 mM 
HEPES, 150 mM NaCl, 4 mM MgCl2, 0.05 mM CaCl2, 0.5 mM ATP, 1 mM PMSF, 1 
mM DTT, 0.02% BSA) with 2x protease inhibitor cocktail I (PIC I) and protease 
inhibitor cocktail II (PIC II)) from 1000x stocks .  1000x PIC I stock contained 1 mg/mL 
leupeptin, 2 mg/mL antipain, 10 mg/mL benzamidine, 10 KIU/mL aprotinin in H2O.  
1000x PIC II contained 1 mg/mL chymostatin, and 1 mg/mL pepstatin in dimethyl 
sulfoxide.  Lysates were evaluated for fluorescence using a fluorimeter and a standard 
curve for EGFP/YFP concentration.   His-VD1, His-VD1A50I, His-Vh, His-VhA50I: pET 
expression vectors were transformed into BL21(DE3) (Stratagene) competent cells.  
Bacterial cultures were grown to an OD600 of 0.6 in LB medium + 1% glucose at 37°C, 
and then induced with 0.5 mm isopropyl-1-thio-β-d-galactopyranoside (IPTG) for 4 hrs at 
37°C.  His-tagged VD1 and VD1A50I were isolated using nickel affinity 
chromatography with Ni-NTA resin (Qiagen) as described previously (Steimle et al., 
1999).  Thrombin cleavage of His-VD1 and His-VD1A50I:  His-tagged proteins were 
cleaved with biotinylated thrombin (Novagen, 1U per 3mg His-tagged protein) for 22 hrs 
at 4°C to remove their N-terminal His6 tags. Proteins were dialyzed into Fusion Protein 
Storage (FPS) buffer (10  mM Tris, pH 7.5, 100  mM NaCl, 0.1 mM EDTA, 0.1 mM 
EGTA, 0.02% azide, 0.1% β-mercaptoethanol), supplemented with 2x PIC I and PIC II, 
and snap frozen in liquid nitrogen.  Chicken gizzard vinculin was isolated as previously 




Cytoskeletal stretch assay:  Silicone stretch chambers (B-Bridge) were coated with 
human plasma fibronectin at 20 μg/ml in Dulbecco's phosphate-buffered saline (DPBS, 
Gibco 33016) and plated with 2.5x105 Vcl-null cells in DMEM supplemented with 10% 
FBS (Hyclone), 2 mM glutamine (Gibco 25030), penicillin (5 μg/mL), and gentamycin 
(20 μg/mL).  After 2 days (~80% confluency), the cells were rinsed twice with warm 
DPBS (37°C) and crosslinked to the fibronectin substrate using the cell impermeable 
reversible crosslinker 3,3´-Dithiobis(sulfosuccinimidylpropionate) (Sigma) at 1 mM 
dissolved in DPBS for 15 min at 37°C.  The cells were rinsed 2x and the crosslinking 
reaction quenched with 50 mM Tris-HCl in DPBS pH 7.5 for 15 min at 37°C.  The cells 
were then rinsed 2x with Stretch Assay Buffer (SAB) (20 mM HEPES, 150 mM NaCl, 4 
mM MgCl2, 0.05 mM CaCl2, 0.5 mM ATP, 1 mM PMSF, 1 mM DTT, 0.02% BSA) 
before being incubated with 0.003% digitonin in SAB+ (SAB buffer supplemented with 
2x PIC I and 2x PIC II) to create digitonin-insoluble cytoskeletons.  The resulting 
cytoskeletons were rinsed once with SAB+ and stretched 15% uniaxially on a Strex 
mechanical strain instrument (B-Bridge).  Exogenous proteins diluted in SAB+ were 
immediately added and the system was stretched for 5 min at 37°C.  Stretched 
cytoskeletons were then rinsed with SAB+ before adding 100 μL of 0.1% Triton X-100 
diluted in SAB+.  Samples were scraped from the silicone substrate using the rounded 
edge of a pipette tip and stored at 0°C.    
Co-immunoprecipitation for talin-VD1 interaction:  100 μL of Ni-NTA beads were 
coupled to His-TnRAvi (AA 432-884, 5 VBSs) and His-TnR1655 (1655-1882, no VBSs) 
for 1.5 hrs at room temperature in 1 mL of 100-μM protein solutions for a final 
concentration of 1 mM talin rod construct on Ni-NTA beads.  1 mM TnR coupled to Ni-
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NTA beads (TnRAvi:  200 μg on 4 μL of beads, TnR1655: 242 μg on 4 μL of beads) was 
incubated with a 3-μM solution of thrombin-cleaved VD1 (Tc-VD1) in a 100 μL 
reaction.  All necessary dilutions were done in SAB+.  After incubations ranging from 2-
60 min, the beads were rinsed 2x with SAB+ and bound complexes were eluted with 2x 
laemmli sample buffer.  After washing, the samples were eluted with Laemmeli sample 
buffer and run on 4-12% Bis-Tris gels in MES buffer.  Gels were imaged using the 700 
nm detector on a Licor Infrared Scanner.   
 
Immunoblotting:  Western blots were developed with species-specific infrared secondary 
antibodies  (Li-Cor) per the manufacturer's instructions.  Murine monoclonal G-11 anti-
vinculin was obtained from Sigma  and used at a 1:250 dilution. Murine monoclonal C4 
anti-actin was a gift from Dr. Jim Lessard.  Affinity purified rabbit C22 anti-talin  was 
raised against C-terminal 22 amino acids of talin rod.  C4 and C22 were used at a 1:4000 
dilution. 
 
Microscopy:  Vcl-null cells were plated onto either poly-L-lysine treated coverslips 
coated with 20 μg/mL human plasma fibronectin or fibronectin-coated stretch chambers 
and allowed to reach ~80% confluency.  Cytoskeletons were created as described above 
and fixed using 4% paraformaldyhyde in ddH2O pH 7.3 at room temperature for 30 min 
and blocked using 2% goat serum.  G-11 anti-vinculin was used at 1:50 and C22 anti-
talin at 1:4000.  Coverslips were mounted in Prolong Gold Anti-Fade solution with 
DAPI. Confocal images were acquired on an upright LSM 510 (Carl Zeiss, Germany) 
microscope using Zeiss AIM software. Digital images were imported into Adobe 
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Photoshop for figure preparation.  All other images were acquired on a Nikon Eclipse Ti 
using Elements software.    
 
Results:   
 
I have previously described how I developed an assay to test the binding of exogenous 
eGFP-tagged proteins to digitonin-insoluble cytoskeletons (Chapter 3, Figure 3-4).  I 
characterized this assay by determining whether digitonin-insoluble cytoskeletons created 
from Vcl-null MEFs could reproduce the published finding that paxillin binds in a 
stretch-dependent manner to cytoskeletons.  To do this, I incubated Vcl-null digitonin-
insoluble cytoskeletons with 100-nM YFP-paxillin created by transfecting HEK cells.  
Using Western blots, I determined the binding of YFP-paxillin to unstretched and 
stretched Vcl-null digitonin-insoluble cytoskeletons that had been stretched 15% 
uniaxially using a commercial Strex machine.  Over three experiments, I found that YFP-
paxillin bound in a stretch-dependent manner to digitonin-insoluble cytoskeletons, with 
stretch inducing a 3-fold increase in the binding of YFP-Paxillin (Figure 4-1).  Since 
YFP-paxillin bound in a stretch-dependent manner, I concluded that my assay created 
cytoskeletons similar to those used in a previous study to identify focal adhesion proteins 
that bound in a stretch-dependent manner (Sawada and Sheetz, 2002).  I then decided to 
use this assay to test the hypothesis that vinculin’s ability to bind to a cytoskeleton is 




My first experiment in this study was to determine whether full-length vinculin showed 
stretch-dependent binding to Vcl-null digitonin-insoluble cytoskeletons using my assay.  
To do, this I incubated Vcl-null digitonin-insoluble cytoskeletons with 100-nM eGFP-
vinculin created by transfecting HEK cells.  Using Western blots, I determined the 
binding of eGFP-vinculin to unstretched and stretched Vcl-null digitonin-insoluble 
cytoskeletons that had been stretched 15% uniaxially using a commercial Strex machine.  
Over three experiments, I found that eGFP-vinculin did not bind in a stretch-dependent 
manner to digitonin-insoluble cytoskeletons (Figure 4-1).  This result was in agreement 
with the results of a previous study showing that full-length vinculin does not bind in a 
















Figure 4-1:  Initial results on the binding of exogenous proteins to digitonin-insoluble 
cytoskeletons replicated previously published results regarding YFP-paxillin and full-
length vinculin.  Vcl-null cells were plated on fibronectin-coated, silicone-based cell culture 
chambers and allowed to recover for 48 hrs.  Digitonin-insoluble cytoskeletons were then created 
and incubated with exogenous proteins diluted in SAB+ at 37°C for 5 min.  Cytoskeletons were 
either left unstretched or stretched 15% uniaxially using a commercial Strex machine. Samples 
were scraped from the chambers in a 0.1% Triton solution and western blots were quantified 
using infrared densitometry.  A)  Representative Western blots showing binding of exogenous 
proteins to digitonin-insoluble cytoskeletons in the unstretched and stretched mechanical states.  
B)  Quantitation of Western blots for each exogenous protein.  Three experiments were quantified 
for each protein.  Bars indicate the S.E.M.  In addition to replicating previously published results, 
these findings suggest that vinculin’s ability to bind to talin or alpha-actinin (demonstrated by the 







I then decided to test the hypothesis that vinculin’s ability to bind to a cytoskeleton is 
dependent on the accessibility of the talin-binding site on vinculin head.  To do this, I 
wished to use a truncation mutant of vinculin that contains only domain 1 (VD1) and is 
therefore incapable of autoinhibition and contains a talin-binding site.  However, before I 
could analyze the binding of VD1 to unstretched and stretched cytoskeletons, I first 
wanted to determine whether recombinant VD1 is capable of binding talin under the 
conditions of my assay.  The Craig lab has unpublished data showing that 0.5-1-μM 
purified recombinant VD1 purified from bacteria is capable of co-immunoprecipitating 
90% of 100-nM eGFP-talin from transfected HEK cell lysate.  However, these 
experiments had also shown that successful co-immunoprecipitation of the majority of 
eGFP-talin in HEK lysates required overnight incubation at 37°C.  I interpreted this data 
as indicating that since VD1 has a high affinity for talin in solution, exogenous 
recombinant VD1 purified from bacteria might be capable of binding accessible talin in 
Vcl-null digitonin-insoluble cytoskeletons.  However, it was unclear on what timescale 
this interaction could occur.   
 
To determine whether recombinant VD1 in solution might be capable of binding 
immobilized talin present in Vcl-null digitonin-insoluble cytoskeletons, and the time 
period needed for this binding, I attempted to co-immunoprecipitate soluble recombinant 
VD1 purified from bacteria with TnRAvi, a portion of talin rod (AA482-911) that 
contains 5 vinculin binding sites that are cryptic within full-length talin rod.  As a 
negative control, I attempted to co-immunoprecipitate soluble, recombinant VD1 purified 
from bacteria with TnR1655, a portion of talin rod (AA1655-1882) that contains no 
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vinculin binding sites.  Ni-NTA beads were coupled with these talin rod constructs at 
high concentration (1 mM) to mimic the localization of talin in focal adhesions.  In each 
of these co-immunoprecipitationss, 1-mM TnR coupled to Ni-NTA beads (200 μg TnR 
construct in 4 μL of beads) were incubated with 3-μM VD1 in stretch assay buffer with 
protease inhibitors (SAB+) at 37°C.  My results show that co-immunoprecipitation of 
VD1 with TnRAvi occurs within 2 min of incubation (Figure 4-2).  There was no 
detectable co-immunoprecipitation of VD1 with TnR1655.  I interpreted this to mean that 
3-μM soluble recombinant VD1 would be capable of binding any available vinculin 
binding sites on cytoskeletal talin on the time scale of a minute.  I chose to allow soluble 
recombinant VD1 to incubate with cytoskeletons for 5 min in the hopes of maximizing 
potential binding between VD1 and cytoskeletal talin.  This incubation time was also 
similar to the incubation times used by Sawada (2 min) to determine the stretch-
dependent binding of exogenous paxillin and FAK to Triton-insoluble cytoskeletons 













Figure 4-2:  VD1 is capable of binding to talin rod constructs with available vinculin 
binding sites.  100 μL of Ni-NTA beads were coupled to His-TnRAvi (AA 432-884, 5 VBSs) and 
His-TnR1655 (1655-1882, no VBSs) for 1.5 hrs at room temperature in 1 mL of 100-μM protein 
solutions for a final concentration of 1-mM talin rod construct on Ni-NTA beads.  1-mM TnR (200 
μg TnRAvi on 4 μL of beads; 242 μg TnR1655 on 4 μL of beads) was incubated with a 3-μM 
solution of thrombin-cleaved recombinant VD1 (Tc-VD1) purified from bacteria in a 100 μL 
reaction at 37°C.  After washes, the samples were eluted with Laemmeli sample buffer and run 
on 4-12% Bis-Tris gels in MES buffer.  The gel was stained with Coomassie blue and imaged 
using the 700 nm detector on a Licor Infrared Scanner.  Lanes:  1) Benchmark ladder 2) Protein 
standards for TnRAvi and VD1, 3) 2 min co-immunoprecipitation between TnAvi and VD1, 4) 









I then proceeded to incubate Vcl-null digitonin-insoluble cytoskeletons with 3-μM 
recombinant VD1 purified from bacteria.  A preliminary experiment showed that 3-μM 
and 1-μM recombinant VD1 purified from bacteria demonstrated similar stretch-
dependent binding to unstretched and stretched Vcl-null digitonin-insoluble cytoskeletons 
that had been stretched 15% uniaxially using a commercial Strex machine (data not 
shown).  To conserve protein, I proceeded to repeat the experiments using 1-μM 
recombinant VD1 purified from bacteria.  Over three experiments, I found that 1-μM 
recombinant VD1 purified from bacteria bound in a stretch-dependent manner to 
digitonin-insoluble cytoskeletons, with stretch inducing a 2-fold increase in the binding 
of recombinant VD1 (Figure 4-1).   
 
I then probed the binding of a vinculin mutant, VD1A50I, that is domain 1 of vinculin 
containing a mutation that ablates vinculin:talin and vinculin:alpha-actinin interactions 
(Bakolitsa et al., 2004).  Using VD1A50I would allow me to determine whether the 
stretch-dependent binding of VD1 was occurring through binding to either talin or alpha-
actinin.  I incubated Vcl-null digitonin-insoluble cytoskeletons with 1-μM recombinant 
VD1A50I purified from bacteria.   Using Western blots, I determined the binding of 1-
μM recombinant VD1A50I to unstretched and stretched Vcl-null digitonin-insoluble 
cytoskeletons that had been stretched 15% uniaxially using a commercial Strex machine.  
Over three experiments, I found that recombinant VD1A50I did not bind in a stretch-
dependent manner to digitonin-insoluble cytoskeletons (Figure 4-1).  Additionally, the 
binding of recombinant VD1A50I was lower than the binding of recombinant VD1.  I 
interpreted these results to mean that recombinant VD1 was binding to cytoskeletons 
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through its talin/alpha-actinin binding site, and that the application of stretch was 
potentially uncovering cryptic binding sites on cytoskeletal talin for vinculin.  
 
However, there were caveats to comparing the stretch-dependent binding of vinculin 
versus VD1 to digitonin-insoluble cytoskeletons.  In this initial study, paxillin and 
vinculin were isolated from HEK lysates and exposed to cytoskeletons at 100-nM while 
VD1 and VD1A50I were purified from bacteria and used at 1-μM concentrations.  These 
different protein sources reflect technical limitations in our ability to easily purify these 
four different proteins using the same method.  Paxillin cannot be isolated from bacterial 
cultures.  Purification of full length vinculin from bacteria often yields numerous 
breakdown products.  VD1 and VD1A50I are very difficult to transfect into mammalian 
cells (low transfection rate), and transfected cells yield lysates with extremely low 
concentrations of eGFP-VD1 or eGFPVD1A50I.  Before committing to other more 
difficult methods of protein purification to address these issues, I decided to determine 
where the recombinant VD1 purified from bacteria bound in Vcl-null digitonin-insoluble 
cytoskeletons.  This would allow me to determine whether the stretch-dependent binding 
of vinculin was specific and whether the VD1 was binding to already formed focal 
adhesions in the digitonin-insoluble cytoskeletons.     
 
To determine the localization of VD1 when incubated with digitonin-insoluble 
cytoskeletons, I created two sets of samples.  First, Vcl-null cells were plated onto 
fibronectin-coated coverslips and digitonin-insoluble cytoskeletons were created as 
previously described.  These coverslips were then incubated with 1-μM recombinant 
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VD1 purified from bacteria for 5 min at 37°C.  As a control, I created Vcl-null digitonin-
insoluble cytoskeletons on coverslips that were incubated in SAB+ buffer with no 
recombinant VD1 protein.   These coverslips were immunostained for endogenous talin 
and VD1.  Attempts to image these coverslips using widefield microscopy proved 
difficult because the VD1 signal was blurry and no single z-plane yielded clear images of 
the VD1 localization.  I interpreted this as indicating that the VD1 signal may have a 3-
dimensional aspect and that VD1 may be binding throughout the entirety of the digitonin-
insoluble cytoskeletons.   The coverslips were then imaged with confocal microscopy 

















Figure 4-3:  Confocal micrographs show that VD1 does not localize to the focal adhesions 
of digitonin-insoluble cytoskeletons.  (A-F) Vcl-null digitonin-insoluble cytoskeletons were 
made on fibronectin-coated coverslips as previously described.  (A-C)  Vcl-null digitonin-insoluble 
cytoskeletons were incubated with 1-μM recombinant VD1 purified from bacteria in SAB+.  (D-F) 
Vcl-null digitonin-insoluble cytoskeletons were incubated with SAB+ containing no recombinant 
VD1.  Vinculin was detected with murine monoclonal G-11 anti-vinculin (1:250).  Talin was 
detected with affinity-purified rabbit C22 anti-talin (1:2000).  Murine anti-vinculin was detected 
with 488 donkey anti-mouse Ig (DaMIg) secondary antibody.  Rabbit C22 anti-talin was detected 
with RRX DaRIg.  The nucleus was stained with DAPI.  All images were taken with a 60x DIC 
objective, N.A. = 1.4.  Red bar = 30 μm.  (A-C) Control stainings for murine monoclonal G-11 anti-
vinculin and 488 donkey anti-mouse Ig secondary antibody. (A) Incubation with murine 
monoclonal G-11 anti-vinculin (G-11) alone results in some background staining and 
autofluorescence (B) Incubation with 488 donkey anti-mouse Ig secondary antibody alone 
indicates that Vcl-null digitonin-insoluble cytoskeletons have some autofluorescence (C) Vcl-null 
digitonin-insoluble cytoskeletons immunostained for both endogenous talin (red) and VD1 (green) 
show that there is some background fluorescence in cytoskeletons alone.  Negative control.  (D-
F) Staining for localization of exogenous recombinant VD1 on Vcl-null digitonin-insoluble 
cytoskeletons.  (D) Incubation with murine monoclonal G-11 anti-vinculin (G-11) alone results in 
some background staining and autofluorescence.  (E) Incubation with 488 donkey anti-mouse Ig 
secondary antibody alone indicates that Vcl-null digitonin-insoluble cytoskeletons show very little 
background secondary staining.  (F)  Vcl-null digitonin-insoluble cytoskeletons incubated with 1-
μM recombinant VD1 immunostained for both endogenous talin (red) and VD1 (green) show that 
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Figure 4-4:  Confocal micrograph showing the punctate, cytoskeletal binding of 
exogenous VD1 to Vcl-null cytoskeletons.  This is an enlarged picture of Figure 4-3F.  Vcl-null 
digitonin-insoluble cytoskeletons were made on fibronectin-coated coverslips as previously 
described and then incubated with 1-μM recombinant VD1 purified from bacteria in SAB+ for 5 
min at 37°C.  Vinculin was detected with murine monoclonal G-11 anti-vinculin (1:250).  Talin was 
detected with affinity-purified rabbit C22 anti-talin (1:2000).  Murine anti-vinculin was detected 
with 488 donkey anti-mouse Ig secondary antibody.  Rabbit C22 anti-talin was detected with RRX 
DaRIg.  The nucleus was stained with DAPI.  All images were taken with a 60x DIC objective, 
N.A. = 1.4.  Red bar = 30 μm.    Exogenous recombinant VD1 binds to cytoskeletons and the not 
fibronectin-coated coverglass.  The binding pattern of exogenous recombinant VD1 is punctate 
and not consistent with any known localization of vinculin.  VD1 largely does not colocalize with 















These confocal images showed that recombinant VD1 bound to cytoskeletons with no 
detectable binding to the fibronectin-coated coverslips.  However, the binding of 
recombinant VD1 was punctate and did not correspond with any known localization 
pattern of vinculin.  Although a very minor amount of VD1 did co-localize with talin, it is 
likely that this was due to random coincidence.  Since these images were taken using 
cytoskeletons adherent to coverslips, I decided to image cytoskeletons adherent to 
silicone-based cell culture chambers and determine if VD1 colocalization with talin 
increased with stretch.  Attempts to compare the localization of VD1 in unstretched and 
stretched cytoskeletons uncovered the technical limitation that confocal microscopy 
cannot be performed through these silicone substrates with sufficient resolution to clearly 
image focal adhesions (Figure 4-5).  The different refractive indexes of PDMS (the 
silicone base of commercially available stretch chambers) versus German coverglass (1.4 
versus 1.515) (MIT, 2012) leads to a greater dispersion of light and low-quality images.  
However, these images also showed stretch-dependent binding of VD1 to digitonin-












Figure 4-5:  Confocal microscopy of unstretched and stretched Vcl-null cytoskeletons 
incubated with exogenous 1-μM VD1.  Vcl-null cytoskeletons were made on fibronectin-coated 
silicone-based cell culture chambers as previously described and then incubated with 1-μM 
recombinant VD1 purified from bacteria in SAB+ for 5 min at 37°C.  Vinculin was detected with 
murine monoclonal G-11 anti-vinculin (1:250).  Talin was detected with affinity-purified rabbit C22 
anti-talin (1:2000).  Murine anti-vinculin was detected with 488 donkey anti-mouse Ig secondary 
antibody.  Rabbit C22 anti-talin was detected with RRX DaRIg.  The nucleus was stained with 
DAPI.  All images were taken with a 60x DIC objective, N.A. = 1.4.  Red bar = 20 μm.    
Cytoskeletons were imaged through silicone to determine the differences in VD1 localization 
between unstretched and stretched cytoskeletons.  However, a larger pinhole than optimal 
pinhole size was required to image through silicone, resulting in lower resolution using the same 
magnification objective. (A) Unstretched Vcl-null cytoskeleton incubated with VD1.  (B) Stretched 









These images (Figures 4-3, 4-4, and 4-5) showed that exogenous recombinant VD1 did 
not localize to the focal adhesions of digitonin-insoluble cytoskeletons.  This prompted 
me to image the localization of full-length vinculin bound to digitonin-insoluble 
cytoskeletons (Figure 4-6).  To do so, Vcl-null cells were plated onto German glass 
coverslips and Vcl-null digitonin-insoluble cytoskeletons were created as previously 
described.  These coverslips were then incubated with 100-nM eGFP-vinculin from 
transfected HEK lysate for 5 min at 37°C.  As a control, I created digitonin-insoluble 
cytoskeletons from Vcl-null cells that had been transiently transfected with eGFP-
vinculin.   These coverslips were immunostained for endogenous talin and VD1.  The 
coverslips were then imaged using widefield fluorescence (Figure 4-6).   These images 
showed that eGFP-vinculin transfected into Vcl-null cells colocalizes with talin and is 
found in focal adhesions. However, exogenous eGFP-vinculin from transfected HEK cell 













Figure 4-6:  Unlike transiently transfected eGFP-vinculin, exogenous eGFP-vinculin from 
HEK lysate does not localize to focal adhesions when incubated with digitonin-insoluble 
cytoskeletons.  (A-C) Vcl-null cells transiently transfected with eGFP-vinculin were converted to 
digitonin-insoluble cytoskeletons as previously described.  (D-F) Vcl-null digitonin-insoluble 
cytoskeletons were made on fibronectin-coated coverslips as previously described and then 
incubated with 100-nM eGFP-vinculin from transfected HEK cell lysate in SAB+ for 5 min at 37°C.  
Vinculin was detected with murine monoclonal G-11 anti-vinculin (1:250).  Talin was detected with 
affinity-purified rabbit C22 anti-talin (1:2000).  Murine anti-vinculin was detected with 488 donkey 
anti-mouse Ig secondary antibody.  Rabbit C22 anti-talin was detected with RRX DaRIg.  The 
nucleus was stained with DAPI.  All images were taken with a 40x ELWD Phase objective, N.A. = 
0.6.  Red bar = 20 μm.    (A-C) Vcl-null cells transiently transfected with eGFP-vinculin.  (A) Vcl-
null cells with transiently transfected eGFP-vinculin show endogenous talin in focal adhesions.  
(B) Vcl-null cells with transiently transfected eGFP-vinculin show endogenous talin in focal 
adhesions.  (C) Overlay of the endogenous talin and transfected eGFP-vinculin signals show that 
talin and eGFP-vinculin colocalize.  (D) Endogenous talin in Vcl-null cytoskeletons localizes to 
focal adhesions.  (E) Exogenous eGFP-vinculin isolated from transfected HEK cell lysate binds to 
cytoskeletons but does not localize to focal adhesions. (F) Overlay of the endogenous talin and 
exogenous eGFP-vinculin signals shows that endogenous talin and exogenous eGFP-vinculin do 








The images showing the localization of exogenous recombinant VD1 (Figure 4-4) and 
exogenous eGFP-vinculin from transfected HEK cell lysate (Figure 4-6, D-F) made me 
suspect that my initial findings showing stretch-dependent binding of VD1 to Vcl-null 
cytoskeletons was an artifact of the conditions of my assay and some spurious ability of 
VD1 to interact with cytoskeletons.  To confirm my earlier findings with VD1 and 
VD1A50I, I attempted to express both VD1 and VD1A50I in HEK cells in order to repeat 
the binding assays.  However, I found that it was not possible to collect eGFP-VD1 or 
eGFP-VD1A50I lysates with concentrations near 100 nM.  As an alternative, I expressed 
vinculin head (Vh, AA 1-851) and a mutant of vinculin head also containing the A50I 
mutation (VhA50I) in HEK cells.  I considered Vh an acceptable substitution for VD1 
since it is also a truncation mutant of vinculin capable of binding talin and alpha-actinin 
that lacks the tail domain.  As a result, Vh is incapable of autoinhibition.   
 
To determine whether eGFP-tagged vinculin-truncation mutants would also show stretch-
dependent binding to digitonin-insoluble cytoskeletons, a panel of stretch experiments 
was completed in triplicate (Figure 4-7).  These experiments compared the binding of 
exogenous full-length vinculin to the binding of exogenous Vh and VhA50I using 
proteins from bacterial purifications, HEK lysates, and in one experiment, vinculin and 
vinculin head isolated from chicken gizzard.  These experiments showed no stretch-
dependent binding of vinculin head (Vh) and no change in binding between Vh and 
VhA50I.  Of all the experiments I conducted on the stretch-dependent binding of 
exogenous proteins to digitonin-insoluble cytoskeletons, only two showed stretch 
dependence:  paxillin (which is a previously published result) and VD1.  This indicated 
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that the stretch-dependent binding of VD1 observed earlier, while replicable, likely does 
























Figure 4-7:  The stretch-dependent binding of recombinant VD1 purified from bacteria 
likely does not reflect a biological function of activated vinculin.  Vcl-null cells were plated 
on fibronectin-coated, silicone-based cell culture chambers and allowed to recover for 48 hrs.  
Digitonin-insoluble cytoskeletons were then created and incubated with exogenous proteins 
diluted in SAB+ at 37°C for 5 min.  Cytoskeletons were either left unstretched or were stretched 
15% uniaxially using a commercial Strex machine. Samples were scraped from the chambers in a 
0.1% Triton solution and western blots were quantified using infrared densitometry.  The prefix 
“Tc-” indicates a recombinant protein purified from bacteria and thrombin cleaved to remove the 
6xHis-tag.  All proteins purified from bacteria were used at a concentration of 1 μM diluted in 
SAB+.  The prefix “EGFP-” indicates proteins present in transfected HEK cell lysate and these 
proteins were used at a concentration of 100 nM, as determined by fluorimetry and standard 
curves generated with eGFP standards.  Chicken gizzard vinculin had some break down during 
purification, but the relative binding of full-length vinculin versus vinculin head could be 
distinguished and compared on western blot.  Data for eGFP-vinculin, YFP-paxillin, Tc-VD1, Tc-
VD1A50I, and chicken gizzard vinculin were collected using a commercial Strex machine that 
stretched the silicone-based cell culture chambers 15%.  All other experiments were stretched on 
a previously characterized manual device that stretched the silicone-based cell culture chambers 
14.1%.  All experiments were repeated 3 times with the exception of the assay performed with 















Discussion:   
 
Prior to this work, a previous study had shown that full-length vinculin did not bind in a 
stretch-dependent manner to cytoskeletons while paxillin and FAK, two other focal 
adhesion proteins, did.  I began this study hoping to determine whether activated vinculin 
could bind in a stretch-dependent manner to cytoskeletons.  To pursue this question, I 
created Vcl-null digitonin-insoluble cytoskeletons and incubated them with YFP-paxillin 
from transfected HEK cell lysate.  These experiments reproduced the previously 
published finding that YFP-paxillin binds to cytoskeletons in a stretch-dependent manner. 
I interpreted this as evidence that my method of creating Vcl-null digitonin-insoluble 
cytoskeletons and introducing uniaxial stretch (both from commercial and manual 
devices) was sufficient to probe the binding of vinculin and various vinculin mutants to 
cytoskeletons.  I followed my experiments with YFP-paxillin with experiments exploring 
the stretch-dependent binding of eGFP-vinculin from transfected HEK cell lysate.  I also 
explored the binding of recombinant VD1 and VDA50I, two truncation mutants of 
vinculin that lack the tail domain of vinculin and are therefore incapable of 
autoinhibition.  VD1A50I was used a control to determine whether any stretch-dependent 
binding of VD1 to cytoskeletons could be occurring through VD1:talin or VD1:alpha-
actinin interactions.   
 
Initial data in this study supported my hypothesis, with exogenous VD1 showing 
increased binding with stretch while exogenous vinculin showed no stretch-dependent 
binding (Figure 4-1).  However, imaging studies showed that VD1 bound to 
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cytoskeletons in a punctate pattern that is not consistent with any known localization 
pattern of vinculin.  Furthermore, VD1 did not localize to focal adhesions.  Experiments 
using another truncation mutant of vinculin (Vh and VhA50I, AA 1-851) incapable of 
autoinhibition also showed no stretch-dependent binding.  Based on these results, I 
suspect that while the stretch-dependent binding of VD1 is replicable, it is likely related 
to a spurious binding ability of VD1.  VD1 crystalizes (Izard et al., 2004) and is an intact 
subdomain of vinculin head capable of binding both Vt and talin (Gilmore et al., 1992; 
Bakolitsa et al., 2004).  However, the Craig lab has unpublished data showing that VD1 
has a tendency to aggregate in solution.  This may occur because of the exposed 
hydrophobic surfaces on VD1 that are usually buried when full-length vinculin is 
autoinhibited or when full-length vinculin interacts with its ligands (Bakolitsa et al., 
2004).  Perhaps this tendency to self-associate in some way mediated the stretch-
dependent-binding of VD1 to cytoskeletons.  It is possible that the VD1:VD1 interaction 
is stronger than the VD1:talin interaction, although there are no published studies on this.  
Aggregation of VD1 would explain the punctate binding pattern of VD1 to cytoskeletons 
(Figure 4-4).  Due to the availability of alternative autoinhibition mutants of vinculin, we 
did not take steps to characterize the extent or source of VD1-mutant aggregation or why 
VD1 bound in a stretch-dependent manner to Vcl-null digitonin-insoluble cytoskeletons 
while Vh did not.   
 
I acknowledge that the developed system is very much in vitro and heavily dependent on 
the buffer conditions for each step.  However, the conditions were sufficient to replicate 
previously published data showing paxillin’s increased binding to stretched 
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cytoskeletons.  Based on those results, it seemed reasonable to use this same cytoskeletal 
system to study the role of vinculin autoinhibition in regulating vinculin’s binding to 
cytoskeletons.   In fact, I considered my system an improvement over the published 
cytoskeletal assay to detect stretch-dependent binding because my assay probes the 
binding of vinculin using cytoskeletons generated from Vcl-null mouse embryonic 
fibroblasts (MEFs).  This ensures that any effect would be due only to the response of 
exogenous vinculin. Indeed, this system showed that exogenous proteins bound to only 
digitonin-insoluble cytoskeletons and not to the fibronectin-coated substrates (Figures 4-3 
thru 4-6).  I am interpreting these results as evidence that while the cytoskeletons I 
generated may have been intact enough to prompt paxillin binding, the process of cell 
permeabilization and the creation of the cytoskeletons might have a) washed away a key 
localization factor for vinculin or b) uncovered less specific or different vinculin ligands, 
prompting diffuse binding of vinculin and abrogating any localization to talin-containing 
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In my opinion, future work based on the experiments presented in this thesis should be 
based on the work presented in “Chapter 3: The Role of Vinculin Autoinhibition in the 
Recruitment of Vinculin to Uniaxially Stretched Cytoskeletons”.   However, in order to 
proceed with this work, several limitations to my system would have to be overcome.  In 
this chapter, I will present both the understood and the predicted barriers to advancing 
this work, as well as several potential alterations in experimental approach that may be 
interesting to the reader. 
 
First and foremost, the reader should understand by this point that the device as presented 
is manually stretched and secured.   While this approach was both cost-effective and 
sufficient for the questions I posed, its simplicity inherently limits future researchers from 
further exploring the role of vinculin in the cellular response to external stretch.  As 
previously explained, the act of stretching the silicone chamber causes a change in the 
coordinates and focal plane of the cells initially photographed.  The delay caused by 
compensating for this position change lead to me to collect images at 5 min intervals to 
ensure that the same timepoints could be collected during each experiment.  Additionally, 
the slight shift in images limited the evaluation of each data image to only peripheral 
focal adhesions instead of the much-preferred approach of tracking the evolution of 
individual focal adhesions.  
 
Ideally, a future system would eliminate both of these shortcomings and allow the 
constant photography of focal adhesions before stretch, during sustained stretch, and after 
the release of stretch so that the evolution of vinculin in focal adhesions can be further 
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studied.  Current Nikon Elements software allows pre-programming of objective 
positioning as well as settings for both the camera and image capture.  It may be worth 
the time investment for future researchers to characterize the exact shift of their stretch 
substrates before data collection and compensate for these movements in order to meet 
the above-specified goals.  An alternative approach would involve designing a simple 
device that introduces stretch from both ends of the silicone chamber, ideally resulting in 
minimal x,y movement of the chamber.  This would involve a relatively simple 
modification of the current device design.   Once accomplished, the microscope user 
would only have to compensate for changes in the z-position of the sample.  This simple 
change from a one-sided to a two-sided stretch system alone would result in higher time 
resolutions and the preservation of additional focal adhesions for analysis.  A final 
alternative approach would be to alter the source of stretch completely by developing an 
approach similar to that of Riveline et al. (Riveline et al., 2001), where a fibronectin-
coated pipette is placed on top of a cell and moved laterally to introduce external stretch. 
Such a system would have to be extensively characterized because it is a complete 
departure from my approach.  However, it is an alternative worth consideration because 
1) modification of the silicone-based stretch device as described above may still not yield 
high enough time resolutions and 2) such an approach would allow the use of total 
internal reflection (TIRF) microscopy.  
  
An additional shortcoming of my previous approach was my dependence on the Vcl-null 
cell-line for my experiments.  The benefit of this cell-line is that a true negative control is 
available for all experiments.  However, this cell-line is difficult to both culture and 
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transfect, and our lab (in collaboration with others) has been unable to make stable  
cell-lines permanently expressing all of the desired vinculin mutants.  As an alternative, I 
began using a transient transfection protocol based on an electroporation approach used 
by our collaborators (Dumbauld et al., 2013).  However, this approach still results in 
large amounts of cell death, low transfection rates, and attempts to co-transfect multiple 
constructs are rarely successful.   Development of a method to express multiple 
fluorescently-tagged protein constructs in Vcl-null cells would allow one to image the 
evolution of a focal adhesion in response to external stretch, instead of limiting the work 
to only collecting data on the response of vinculin.    
 
Finally, I would propose that future researchers build upon the work of Peng et al. (Peng 
et al., 2011), a group of researchers who published a drug cocktail composed of 
jasplakinolide, latrunculin B, and Y27632 that inhibits actin disassembly, actin 
polymerization, and myosin II-based rearrangements, respectively.  Their work showed 
that this cocktail, referred to as JLY, functions within seconds to preserve cell 
morphology and inhibit dynamic actin changes in neutrophil-like HL-60 cells, human 
fibrosarcoma HT1060 cells, and mouse NIH 3T3 fibroblast cells.   Most interestingly, 
they also showed that while actin dynamics are arrested, JLY does not inhibit the ability 
of cells to respond to external stimuli.  Neutrophil-like HL-60 cells treated with JLY had 
no changes in basal calcium levels or the magnitude or kinetics of calcium release.  
Furthermore, the JLY cocktail was used to show that actin dynamics are essential for the 




Together, these results generate some interesting questions about how JLY could be used 
study the response of vinculin to external stretch.  Of course, despite having been shown 
to be effective in mouse NIH 3T3 human fibroblasts, the effects of the JLY cocktail 
would have to be characterized in the Vcl-null cell-line, as well as in each cell-line 
expressing one of the various vinculin constructs.  The ability to co-transfect each  
cell-line expressing a vinculin construct with YFP-actin would allow one to also follow 
actin dynamics throughout the application of stretch.  Then, the researcher would be able 
to design an assay to determine whether any observed changes in vinculin-containing 
focal adhesions in response to stretch were also dependent on functional actin dynamics.   
One could hypothesize that since vinculin tail binds actin (see Chapter 1), actin dynamics 
would be necessary to ensure additional vinculin could be activated in order to respond to 
the stress imposed on the cell by external stretch.   An alternative hypothesis could argue 
that, by freezing actin dynamics, actin would remain bound to vinculin tail, leaving 
vinculin active and capable of binding additional partners, strengthening the focal 
adhesion complex.   
 
The caveat to this line of research is that any vinculin-dependent, stretch-dependent 
changes are happening on a timescale comparable to the effects of the JLY cocktail.  
While Peng et al. reported their JLY cocktail having an effect “within seconds”, most of 
their reported data is on the timescale of minutes.  Therefore, if stretch-dependent 
changes are occurring on the timescale of seconds or less, these changes may occur 
before the JLY cocktail takes effect.  This would render the JLY cocktail inappropriate 
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I am a classically trained operatic soprano and still train at the New York studio of Dr. 
Jean Ronald LaFond.  I love exploring new and different kinds of music and connecting 
new works to those with which I am already familiar.  Often very disparate works can be 
linked by a common theme.  Finding these themes and seeing how they carry over from 
one style of music to another makes unfamiliar works more approachable and a joy to 
learn more about.  In particular, I am fascinated by the history of how American popular 
music transitioned from the opera, to the operetta, and into the foundations of the modern 
American "pop" musical.  They use very different methods to portray similar stories of 
ambition, love, and achievement.   
 
